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CHAPTER 1 
Introduction 
This survey describes advances in bioinstru- 
mentation devices and techniques achieved by 
the National Aeronautics and Space Adminis- 
tration (NASA). Its major aim is to facilitate 
use of NASA contributions in medicine and 
the bioinstrumentation industry. Accordingly, 
the survey is directed largely toward two 
groups: those in medicine who plan, specify, 
and utilize advanced bioinstrumentation sys- 
tems; and those in engineering who design, 
develop, and manufacture them. Together, 
these groups greatly influence the course of 
medical practice and public health. 
I n  the last decade, almost coincident with 
the growth of the space program, there has 
emerged a challenging problem in medicine. 
The problem is dual in nature. First, there is 
an insufficient number of physicians, nurses, 
and paramedical personnel available to handle 
the number of people requiring medical care. 
Secondly, the cost of medical care has be- 
come a significant percentage of the gross na- 
tional product. Solutions to these two problems 
go hand in hand. The productivity of medical 
personnel must be such that the available sup- 
ply of these skills may be stretched to cover an 
ever increasing patient load ; increased pro- 
ductivity will also produce cost savings to the 
ultimate consumer, the patient. 
A good part of the answer to this problem 
of productivity lies with bioinstrumentation 
and its more effective use in all phases of 
medicine. This solution is illustrated by the 
system for mass screening and diagnosis es- 
tablished for subscribers to the Kaiser Foun- 
dation Health Plan in the San Francisco area 
(refs. 1 and 2). The Kaiser “Multiphasic 
Health Checkup” provides an /instantaneous 
computer summary of more than 40 medical 
measurements obkained during a 2% -hour ex- 
amination, for 25 000 patients annually, at 
a cost of about $35 per patient, with complete 
patient acceptance. The system depends heavi- 
ly on sophisticated bioinstrumentation oper- 
ated by aides, and on advanced computer 
methods. Other examples can be found in 
modern hospitals, intensive care units, surgical 
suites, medical data handling, and many other 
situations. But in the main, the tremendous 
potential of current biomedical instrumenta- 
tion has not been fully tapped. This is why 
NASA’s experiences in bioinstrumentation 
planning, development, and application can be 
valuable to the medical community today. 
Bioinstrumentation has been the funda- 
mental tool used by NASA to learn about the 
medical problems of spaceflight. Bioinstru- 
mentation systems have been integrally con- 
nected with the Mercury, Gemini, and Apollo 
programs. Other systems have been applied 
to the biological research and simulation 
studies that support spaceflight activity. The 
conditions of spaceflight impose uniquely strin- 
gent requirements on NASA bioinstrumenta- 
tion, so that system development requires close 
cooperation between medical and engineering 
personnel. Many advances in bioinstrumenta- 
tion technology have resulted. 
I n  its work, NASA makes two main types 
of technological contributions, One is in the 
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production of specific instruments and systems, 
usually for spaceflight. The other is in the 
formulation of systems requirements and 
specifications, and methods for systems devel- 
opment and application. Both types of con- 
tribution are significant. I n  fact, because of 
the specialized nature of spaceflight equip- 
ment, the second may frequently outweigh the 
first. Accordingly, this survey has been organ- 
ized into chapters dealing with basic problem 
areas in bioinstgumentation system develop- 
ment. The objectives are to stress the corre- 
spondence between spaceflight and nonaero- 
space applications and to lay the groundwork 
for subsequent extrapolation of NASA’s ex- 
periences by the reader. Within the selected 
areas, representative examples illustrate 
NASA solutions to system design problems. 
The examples chosen emphasize human moni- 
toring during aerospace flight, but contribu- 
tions to research methodology have also been 
included. 
Choice and classification of examples were 
often difficult. System developments may fit 
into several categories; they may differ only 
slightly from one another; they may be in- 
sufficiently documented ; or their documenta- 
tion may be inaccessible. The authors have 
based their selection on: (1) relevancy to the 
main point of the chapter; (2) estimated im- 
portance of the contribution ; (3) complete- 
ness of available information; and (4), to 
some extent, a lack of previous Technology 
Utilization publication. Information on contri- 
butions was derived from the literature, from 
inquiries, and from personal visits by the au- 
thors to the NASA centers and industrial con- 
tractors involved in their development. 
This survey is not a compendium; it does 
not contain all NASA developments nor even 
all significant developments in a particular 
area. Nor does it trace in detail the history of 
each development. I n  a program like NASA’s, 
system needs may be stated at one organiza- 
tional level, and be filled at quite another level 
by contract and subcontract, funded research, 
or some combination of NASA and outside 
effort. This makes the assignment of individu- 
al credit difficult and frequently controversial. 
For the purposes of this survey, a NASA con- 
tribution is defined as one supported by NASA, 
and only abbreviated indications of industrial, 
institutional, or individual responsibilities in 
its development are provided. Generally, the 
associated references contain more complete 
information of this type. 
Five main areas of NASA bioinstrumenta- 
tion system development are identified in this 
survey. They are: 
(1) Planning-Chapter 2 outlines the tech- 
niques NASA has used to establish informa- 
tion requirements and equipment specification 
for bioinstrumentation system development. 
(2) Seming and signal cond&ming- 
Chapters 3 and 4 deal with the detection of 
physiological signals under aerospace condi- 
tions and with the design of advanced elec- 
tronic instrumentation to process and transmit 
these signals. 
(3) Medical monitoring and duta process- 
ing-Chapters 5 and 6 describe significant 
NASA contributions to data processing, in- 
cluding acquisition techniques, computation of 
derived parameters, and methods of data dis- 
(4) Nemurements in the field-Many of 
NASA’s contributions represent solutions to 
the difficult problems of making laboratory- 
quality measurements in the field. Chapter ‘7 
focuses on this aspect of system development. 
(5) Manufacture-Chapter 8 presents some 
NASA contributions to bioinstrumentation 
fabrication and quality assurance. 
Most chapters end with an application eval- 
uation of the technology described. Here, 
specific nonaerospace applications are dis- 
cussed, along with possible alterations required 
to make space technology economically feasible 
for everyday use. I n  conclusion, chapter 9 
discusses some general factors influencing ap- 
plication of NASA bioinstrumentation de- 
velopments and techniques to nonaerospace 
medicine and industry. 
The survey covers a broad spectrum of de- 
velopments. It need not be read in sequence, 
and the reader with specific bioinstrumenta- 
tion interests may sample freely from chapter 
and section. 
play. 
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CHAPTER 2 
Bioinstrumentation System Requirements 
This chapter presents NASA’s methodology proach are discussed, along with the organiza- 
in establishing information requirements and tional framework used to ensure coordination 
equipment specifications for the bioinstrumen- and timely delivery of required equipment. 
tation systems used on suborbital and orbital The NASA program offers valuable guidelines 
spaceflights (tables 1 & 2). The questions to the planner of bioinstrumentation systems 
and decisions underlying the planning ap- for hospitals, field monitoring, clinical and 
TABLE L-Project Mercury Manned Flights 
Flight 
MR-3 
MR-4 
M A 4  
MA-7 
M A 4  
MA-9 
Crew 
Shepard 
Grissom 
Glenn 
Carpenter 
Schirra 
Cooper 
-., 
Launch date 
May 5,1961 
July 21, 1961 
Feb. 20, 1962 
May 24,1962 
Oct. 3, 1962 
May 15,1963 
Description 
Suborbital 
Suborbital 
Orbital 
Orbital 
Orbital 
Orbital 
Duration 
(hr :min)  
0 :15 
0 :15 
4 :56 
4 :56 
9 :14 
34 :20 
TABLE %--Gemini Manned Spaceflight8 
Gemini 
Mission Crew Launch Date Description 
Duration, 
day :hr :mh 
I11 Grissom Mar. 23, 1965 Third revolution manned test 0.04 :52 
IV McDivitt June 3,1965 First extended duration and extravehicular activity 4 :OO :56 
V Cooper Bug. 21, 1965 First medium-duration flight 7 :22 :56 
VI1 Borman Dee. 4, 1965 First long-duration flight 13 :18 :35 
Young 
White 
Conrad 
Lovell 
Stafford 
. 
VI-A Schirra Dee. 15, 1965 First rendezvous flight 1 :01:53 
5 
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TABLE 2.-Gemini Manned 8 p m e  f Zights-Continued 
Gemini 
Wsion Crew Launch Date Description 
Duration, 
day :hr :min 
VI11 Armstrong Mar. 16, 1966 
IX-A Stafford June 3,1966 
X Young July 18, 1966 
Scott 
Cernan 
Collins 
XI Conrad Sept. 12, 1966 
Gordon 
XI1 Lovell Nov. 11,1966 
Aldrin 
First rendezvous and docking flight 0 :10 :41 
Second rendezvous and docking ; first extended extra- 3 :01:04 
vehicular activity 
Third rendezvous and docking; two extravehicular 2 :Z2 :46 
activity periods ; first docked target vehicle-propelled 
high-apogee maneuver 
First rendezvous and docking initial orbit ; h o  extra- 
vehicular activity periods ; second docked target vehi- 
cle-propelled high-apogee maneuver ; tether exercise 
Rendezvous and docking ; umbilical and two standup 
extravehicular activity periods ; tether exercise 
2 :23 :I? 
3 :22 :37 
physiological research, and similar nonspace 
situations because of its scope, its focus on 
critical medical problems, and its use of spe- 
cially developed, advanced technology. 
Space exploration involves a radical depar- 
ture from the normal environmental conditions 
of human activity, and the physiological well 
being of the astronaut has been a prime focus 
of the entire space program. Medical inputs 
were required early in the Mercury project to 
establish basic system requirements-the med- 
ical information needed and the best means to 
obtain it. Medical personnel have continued to 
play a central role in spaceflight planning. 
Each manned spaceflight has been both a 
unique operational mission and another step 
in a continuing research program. Medical 
monitoring must determine the immediate 
safety of the astronaut and the effect of ob- 
served responses on the conduct of subsequent 
flights. Only a limited amount of bioinstru- 
mentation can be taken into space on each mis- 
sion, so a careful selection must be made of 
physiological variables and measurement 
means. Finally, space bioinstrumentation is 
highly specialized in design and fabrication. 
I ts  development must be begun well before a 
particular mission and controlled closely up to 
the time it is used. Because of these factors, 
and the innate technical complexity of space 
operations, NASA’s work represents a major 
advance in bioinstrumentation system plan- 
ning. 
BACKGROUND 
Since World War 11, scientists have specu- 
lated on the biological implications of space- 
flight. During the 1950s experimental studies 
tried to answer some of the fundamental 
questions raised. These studies concerned man’s 
reactions to weight.lessness, lift-off and reentry 
acceleration, space radiation, noise and vibra- 
tion, and also dealt with the logistics of life 
support, nutrition, and sanitation (ref. 1). By 
mid-1958, some information was available 
from human and animal flights lasting be- 
tween 30 seconds and several minutes. These 
data showed no apparent physiological harm 
for these short flight durations (ref. 2). Con- 
cerning more practical flight times, theoretical 
speculations ran the gamut from predictions 
of severe debilitation and disorientation to 
predictions of no effects’at all. It was generally 
recognized, however, that in light of the po- 
tential dangers to the astronauts, the medical 
community would have to contribute substan- 
tially to the national space program if its goals 
were to bs met. 
Participation of medicine in manned space- 
fight technology did not start with passage of 
the National Aeronautics and Space Act in 
1958. More than 30 years of aviation medicine 
preceded the decisions made then. During 
those years the flight surgeon had often func- 
tioned in the capacity of a medical officer con- 
cerned with normal subjects exposed to an 
“abnormal” environment. It was natural, then, 
for the aviation medical community to con- 
sider space medicine as a new dimension to its 
existing specialty (ref. 1). Nevertheless, de- 
spite some previous experience and the steady 
growth of animal experimentation (refs. 3 and 
4), few hard facts were available to NASA 
scientists as the nation’s manned space pro- 
gram began. 
PLANNING FOR THE MERCURY PROGRAM 
I n  October 1959, a special Committee on 
Life Sciences was formed as a part of the 
Space Task Group at Langley Research Cen- 
ter, Hampton, Va. (ref. 5 ) .  This committee 
was faced with the job of determining the 
medical monitoring requirements for the Mer- 
cury flights. Reviewing previous work and ex- 
trapolating available data, the committee 
found no conclusive evidence that man could 
survive prolonged spaceflight exposure. They 
felt that monitoring of some critical physio- 
logical variables was mandatory, but that the 
variables themselves must be chosen by an en- 
gineering-type tradeoff analysis comparing 
significance and implementation possibilities. 
A biotelemetry system was planned for the 
Mercury capsule. But in light of the flight 
schedulean orbital flight in 196O-develop- 
ment time was short. I n  addition, the whole 
concept of continuous monitoring of physio- 
logical data via telemetry from an active pilot 
was somewhat novel in 1959. Without exag- 
geration, one could say that no equipment 
existed in a form suitable for continuous and 
reliable monitoring in space and that few phy- 
sicians had had experience with analogous 
equipment on Earth. 
Thus the two major questions influencing the 
NASA choice of physiological variables for 
monitoring were: Could man survive space 
exposure? And what instrumentation’ could be 
developed in the time available to measure 
variables related to survival and also meet 
operational requirements of comfort, reliabil- 
ity, compatibility with other spacecraft sys- 
tems, and noninterference with the pilot’s pri- 
mary mission (ref. 6) ? 
A requirement was established early for 
continuous recording of the selected variables, 
which would be made available immediately 
after telemetry acquisition to the ground-based 
medical monitoring team. Continuous records 
were felt necessary to determine the astro- 
naut’s capability of completing a mission and 
to provide clues in the event of precipitous 
collapse. Since survival was the main goal, 
the monitoring philosophy became known as 
“safety monitoring.” 
Medical interest centered on the cardiovas- 
cular system because hydrostatic changes were 
the most obvious concomitant of the weight- 
less state (ref. 6). Instrumentation considera- 
tions consequently focused on the acquisition 
of cardiovascular information. At the same 
time, it was recognized that abnormal indica- 
tions from the cardiovascular system could 
not be explained in terms of weightlessness 
unless other environmental parameters were 
also measured. However, the only cardiovas- 
cular instrumentation that could be developed 
and qualified in time for the first flights was 
for measurement of heart action potentials- 
the electrocardiogram (ECG) . Thus this meas- 
urement became the mainstay of the safety 
monitoring system although others were later 
added. Two pairs of electrodes, yielding two 
ECG leads, were specified to increase reliabil- 
ity. Unfortunately, these lead‘s were in noh- 
standard body locations in order to reduce 
body movement interference. Classical wave- 
form diagnosis was thus sacrificed in favor of 
good information on cardiac rate and rhythm. 
Both central venous blood pressures and 
arterial pressure were considered invaluable. 
But there was no known way to measure the 
former consistent with prudent medical prac- 
tice and spacecraft operational requirements. 
And while continuous arterial pressure was of 
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great interest, particularly during reentry 
following weightless exposure, direct measure- 
ment was out of the question.* Work had beeh 
done on automatic indirect sphygmomanom- 
eters, but no system had been developed to 
the point where it could be qualified for the 
first manned flight (ref. 8). Accordingly, blood 
pressure measurement was not included at  the 
start of the space program, but a semiauto- 
matic apparatus was ready and used on the 
M A 4  Mercury flight. 
Body temperature was also considered a 
critical parameter, largely on the basis of ex- 
perience with near fatal hyperthermia in the 
Man-High balloon flights (ref. 8). Fortunate- 
ly, its instrumentation was realizable. Body 
temperature was monitored on all Mercury 
missions through MA-8 with a thermistor 
rectal probe. I n  the last Mercury flight, which 
was of longer duration, an oral sensor was used 
for pilot comfort. 
Finally, some measure of respiration was 
considered mandatory for safety monitoring. 
Volume and rate information was preferred, 
but rate alone was acceptable. The first Mer- 
cury flights used a thermistor mounted on the 
microphone pedestal in the pilot’s helmet to 
*Both venous and arterial pressure were later 
measured by direct techniques in a chimpanzee flight 
(ref. 7). 
obtain indications of breathing. The therm- 
istor, heated electrically to 200° F, was cooled 
by the movement of air over it during inhala- 
tion and exhalation. This method did not give 
reliable respiration traces and was replaced by 
the impedance pneumograph technique for the 
last two missions (ref. 9), which provided 
satisfactory records. Also, as pointed out in 
chapter 7 of this survey, impedance pneumog- 
raphy reflects chest movement. From the 
standpoint of determining astronaut survival, 
indication of chest movements was more valu- 
able than indication of air flow. Thus imped- 
ance pneumography provided a double gain. 
The “safety-oriented” variables measured dur- 
ing the Mercury flights are summarized in 
table 3. 
In  addition to this information, cabin un- 
vironmental data (pressure, temperature, etc,) 
and voice communication with the astronaut 
were provided to the medical monitoring team. 
The physiological variables measured for Proj - 
ect Mercury were the minimum considered vital 
to ensure pilot safety and give some confidence 
in extending flight time. No measurements were 
taken solely to investigate man’s reaction to 
spaceflight. 
At the end of the Mercury flight series, 
NASA concluded that men could tolerate 
weightless spaceflight for periods up to 34 
hours, and that while data from the onboard 
TABLE 3.-Primary AS’afety Monitoring Varkbles 
for Space Flight Medical Monitoring 
Bioinstrumentation 
Physiological 
variable 
Mercury Gemini Apollo 
EGG waveform 2 leadsa 2 leadsa 1 lead 
Respiratory Thermistor” Impedance Impedance 
waveform impedance pneumographa pneumograph 
Body temperature Rectal probe? Oral sensorb Oral sensorb 
Arterial blood Arm cuff and Arm cuff and Arm cuff and 
pressure microphonea microphones microphoneb 
pneumographa 
oral sensorb 
a Telemetered to ground stations. 
Onboard measurements. 
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biomedical sensors showed changes, these “ab- 
normalities” could be considered normal phys- 
iological responses in the particular flight 
situation (ref. 9). 
It must be emphasized that evaluation of the 
astronaut’s physiological response utilized sev- 
eral information sources in addition *to the 
telemetered physiological variables. These 
sources included control baseline data, voice 
responses in flight, answers to debriefing ques- 
tions, and the detailed postflight physical ex- 
amination. I n  fact, postflight detection of 
orthostatic hypotension (a radical drop in 
blood pressure and rise in heart rate following 
upright tilt) in the last two Mercury missions 
provided the primary indication of a poten- 
tially serious medical problem. This problem, 
termed “circulatory deconditioning,” had also 
been observed by the Russians. It caused some 
apprehension about the 14-day exposure 
planned in the upcoming two-man Gemini 
flights and was a significant medical finding 
of the Mercury program. 
GEMINI PROGRAM PLANNING 
The Mercury safety monitoring philosophy 
was carried over to the Gemini program, 
which involved two-man astronaut teams and 
much longer flights. The same four param- 
eters, namely, electrocardiogram (two leads), 
respiration, body temperature, and blood pres- 
sure, were measured continuously on both 
command pilot and pilot (see table 3). The 
most significant difference was the improve- 
ment in packaging and system design, and the 
addition of an onboard biomedical recorder.* 
On Mercury, only the biomedical sensors 
were located within the pressure suit. From 
the sensors, wires passed out ,through a con- 
nector to signal conditioners packaged on 
plug-in, printed-circuit boards. With Gemini, 
the signal conditioners were miniaturized and 
*Developed for NASA by Cook Electric Go., this 
miniature unit contained seven data channels and 
provided a total record time of 100 hours. It com: 
bined an extremely slow tape speed (0.0293 inch per 
second) with no sacrifice of frequency response in the 
biomedical data channels. 
mounted in pockets on the astronaut’s under- 
garment (see fig. 13, chapter 4). The new ar- 
rangement minimized lead length from the 
sensors, improving the signal quality. I n  addi- 
tion, the Gemini signal conditioners were com- 
pletely redesigned to provide higher input im- 
pedance, higher common mode rejection, lower 
output impedance, higher accuracy, and 
greater stability. 
Although no gross medical problems were 
encountered in the Mercury flights, N A S A  
was concerned that circulatory deconditioning 
might prove a limiting factor to weightless ex- 
posure by reducing the astronaut’s ability to 
withstand reentry acceleration stress. This con- 
cern led to a revision in the planned Gemini 
flight schedule. Flight durations were ap- 
proximately doubled to 14 days (ref. 10). 16 
also led to a change from pure safety monitor- 
ing equipment to inclusion of medical experi- 
ments designed to reveal more subtle body 
changes. The Gemini experiments and their as- 
sociated bioinstrumentation are summarized 
below. 
Experiment M-1-curdhvmcwlur condition- 
ing-No onboard instrumentation utilized. 
Pre- and postflight tilt tests were used to judge 
efficacy of inflatable occlusion leg cuffs. 
Experiment M-3-in-flight exercise-work 
tolerance-Heart rate and blood pressure re- 
sponse to exercise measured with safety in- 
strumentation. 
Experiment M-.4--hflight phonocurdw- 
gram--A piezoelectric microphone was used 
in conjunction with EGG signal conditioner 
and simultaneous ECG and phonocardiogram 
signals were obtained from each pilot and 
recorded on the biomedical recorder. 
Experiment M-5-bkmsays of 6ody flw&3%-- 
No onboard instrumentation utilized. A urine 
sampling and volume measuring system in- 
troduced a fixed quantity of tritiated water in- 
to each voiding. A sample of each voiding was 
taken after adding the isotope. Upon recovery, 
total volume was calculated by measuring the 
dilution of the tritium in the sample. Plasma 
samples were taken postflight. 
Experimemt H-6-6one deminerdization- 
No onboard instrumentation utilized. Pre- and 
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postfliht radiographs were made of the left 
foot in lateral projection and of the left hand 
of each crewman to determine changes in bone 
mass and density. 
Experiment #-7-c&am and nitrogen bal- 
ance-No onboard instrumentation utilized. 
Continuous data on dietary intake of each 
constituent under study and continuous col- 
lection of all urine and stool specimens were 
obtained before, during, and after flight. 
Experiment M-8-in-jEght deep ady8i8- 
Two channels of el e c t roe n ce p h a 1 o g ram s 
(EEG) were measured using two pair of scalp 
electrodes, two signal conditioners, and the on- 
board biomedical recorder. 
Experiment M-9-hZcman otolith fwnction- 
Utilized an onboard vision tester to determine 
disorientation. 
It is significant from a systems design stand- 
point that only two of the Gemini experiments 
utilized bioinstrumentation in addition to the 
safety instrumentation. These were the phono- 
cardiogram experiment (which in fact utilized 
the Gemini ECG signal conditioner plus a 
specially developed microphone) and the EEG 
experiment, which used an entirely new signal 
conditioner. Thus the safety instrumentation 
was able to serve multiple functions in the 
spaceflight program. 
APOLLO PROGRAM PLANNING 
Since approximately 2000 man-hours of 
spaceflight had revealed fewer hazards and 
deleterious effects than anticipated (ref. ll), 
the Apollo safety bioinstrumentation require- 
ments relaxed somewhat the previous require- 
ment for continuous and comprehensive mon- 
itoring. The Apollo program increases the 
flight team size to three with its main objective 
a lunar landing and return. Approximately the 
same measurements will be made on Apollo as 
on Mercury and Gemini, but at  less frequent 
intervals, and for only one of the three astro- 
nauts at a time. Exceptions will be during the 
Extravehicular Activity (EVA) and Lunar 
Excursion Module (LEM) mission phases. At 
these critical times, medical safety information 
transmission will be continuous, although even 
fewer variables will be measured. The change 
in Apollo information requirements was made 
because the successful 14-day Gemini flight 
was considered adequate qualification of man 
for the shorter (but admittedly more arduous) 
8-day lunar mission, and communication will 
be more difficult from Apollo because of anten- 
na orientation problems, distance, lunar shad- 
owing, etc. 
The safety bioinstrumentation planned for 
the Apollo lunar missions is summarized in 
table 3. During EVA and operation of the 
LEM, physiological safety monitoring will 
consist of only one ECG lead, the sternal. Ad- 
ditional information will be available from the 
voice communicthon and spacesuit environ- 
mental data channels. There is no current pro- 
vision for onboard recording. Although the 
Gemini recorder functioned well, the general 
approach was compromised by two design 
factors : (1) lack of a “dump” capability, to 
permit data examination during the mission ; 
and (2) difficulty in converting the necessarily 
specialized recording mode of the ultra-low 
speed recorder to normal formats for sub- 
sequent computer analysis. To NASA, these 
disadvantages were enough to off set the ad- 
vantage of obtaining biomedical data in the 
intervals between telemetry acquisitions of 
Apollo data. Originally, a number of medical 
experiments were planned for Apollo. Some 
repeated those of Gemini, while others were 
new, such as vectorcardiogram and thoracic 
blood flow (cardiac output). These may be 
flown on a subsequent Apollo Applications 
Program. 
ADVANCE MEDKAL PLANNING 
Early in its consideration of manned space- 
flight beyond Apollo, NASA initiated a multi- 
phase program to plan the associated medical 
investigations. I n  Phase I of this program, 
NASA sponsored two studies (conducted by 
North American Aviation, Inc., and Republic 
Aviation Corp.) that were entitled “Biomedi- 
cal and Human Factors Requirements for a 
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Manned Earth-Orbiting Station.” These stud- 
ies, completed in late 1963 (refs. 12 and 13), 
were a first attempt to specify &he requisite 
measurements for a comprehensive scientific 
study of man’s readion and adaptation to the 
space environment, and to provide a prelimi- 
nary conceptual design of instrumentation to 
accomplish the research. Compared to the 
spartan requirements of Mercury, Gemini, and 
Apollo, the proposed measures and their im- 
plementation were imposing, involving a 
spaceborne clinical laboratory, an onboard 
centrifuge facility, and a radiology laboratory. 
In  general, the studies considered all possible 
laboratory techniques which could be useful 
and could possibly be implemented. Out of 
these studies came a number of novel instru- 
menta6on concepts. Typical were several in- 
genious methods of measuring body mass in a 
weightless environment, as well as new tech- 
niques of miniaturized clinical analysis. 
Phase I1 of the program was a study con- 
ducted by Lockheed Missiles and Space Co. in 
response to a NASA Work Statement, which 
condensed the broad results of the Phase I 
study into a practical list of desired measures 
and asked that their conceptual implementa- 
tion be related to specific vehicle configura- 
tions (ref. 14). Completed in early 1965 (refs. 
15 through 19), ,the report constituted a de- 
tailed “Study of Conceptual Design and 
Optimization of Measurement Devices for Bio- 
medical and Human Factors Testing for Or- 
bital Research Laboratory Techniques.” Phase 
I11 of the program (also conducted by Lock- 
heed) was a time line study of the Apollo-X 
configuration, in which the various medi- 
cal measurement procedures were “walked 
through” under terrestrial conditions. This 
work was completed in early 1966 (ref. 20). 
The fourth phase of the effort is currently in 
progress. NASA has selected two contractors 
(Lockheed and General Electric) to define and 
optimize an integrated medical and behavioral 
laboratory measurement system (IMBLMS) . 
This system will provide the capability of con- 
ducting long-term experiments utilizing orbit- 
al workshop vehicles. The laboratory will be 
designed to provide growth potential to con- 
duct medical experiments through early 1970. 
Paralleling the broad studies outlined above, 
“single-shot” planning efforts have been con- 
ducted periodically by NASA and its consult- 
ants (ref. 21). I n  addition, a number of ex- 
periments have been independently proposed 
by specialists in universities and in other gov- 
erment agencies. These are generally quite 
specific (e.g., the effect of prolonged space- 
flight on carotid baroreceptor reflexes and 
arteriolar reactivity). During Phases 11, 111, 
and I V  of the above-mentioned study, par- 
ticipating designers attempted to : (1) verify 
the associated equipment requirements of these 
specialized studies ; (2) to maximize inter- 
changeability of components; and (3) to mini- 
mize complexity, weight, and volume. The 
hardware called for in these planning studies 
remains to be developed. The interested reader 
may consult references 15 through 19 for de- 
tails of the conceptual designs. 
As NASA began the Apollo flights, new 
concepts of bioinstrumentation were evolving. 
This was especially true in the areas of data 
processing and display but also true at the 
level of basic physiology. For example, sub- 
sequent to Gemini VII, NASA evaluated a 
combinatory physiological parameter which 
included respiration rate, respiration depth, 
and rate of change of heart rate. Excellent cor- 
relation was found between this measure and 
estimates of pilot alertness obtained from 
EEG records. NASA envisions that this kind 
of effort to reappraise physiological informa- 
tion sources will lead to predictive indications 
of man’s ability to extend his time in space- 
flight. It matches NASA’s simultaneous efforts 
to adapt its central biomedical monitoring sys- 
tem to the general needs of predictive monitor- 
ing (see chapter 5) .  
BIOINSTRUMENTATION SPECIFICATION AND 
ACQUISITION 
As illustrated by the Mercury program, 
space monitoring systems often represent a 
compromise between information requirements 
and technical limitations. Once it is decided 
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what to monitor, however, a scientifically ac- 
ceptable bioinstrumentation package must be 
produced in time to meet mission schedules. 
NASA has developed procedures to accom- 
plish this task, based on fundamental princi- 
ples of engineering planning, and the special 
requirements of biomedical and space opera- 
tion. Some of these procedures are presented in 
the following section, not as a manual, but as 
a guide to similar planning in other situations. 
The bioinstrumentation package for each 
spacecraft mission is made up of equipment 
from three categories of need. These are : 
(1) Equipment required to measure infor- 
mation requirements originally selected as part 
of the space program. 
(2) Instrumentation required to gather in- 
formation on specific events determined neces- 
sary to fulfill the spacecraft mission, but not 
considered at the onset of the space program. 
(3) Instrumentation associated with basic 
scientific questions, or with the advancement of 
instrumentation technology. 
The first category is the more typical, and 
the flow chart presented in figure 1 illustrates 
most of the major planning elements and deci- 
sion processes required to provide bioinstru- 
mentation for measuring variables selected 
early in mission planning. 
Because of the shortage of space and weight 
allocations on spacecraft and the cost of bio- 
instrumentation, system components should 
serve multiple functions where possible. This 
process is illustrated by the use of the safety 
bioinstrumentation in the Gemini experiments. 
It is being repeated in the acquisition of the 
Apollo Biomedical Experiment Systems. Sen- 
sors, signal conditioners, and voltage convert- 
ers are shared among experimental setups for 
examining such variables as cardiac output by 
the Kubichek thoracic impedance technique 
(ref. 22), and the vectorcardiogram by the 
Frank lead network. Previously, the ECG 
signal conditioner (see chapter 4) proved par- 
ticularly adaptable to multiple use. Its funda- 
mentally broad frequency response and high 
gain make it an excellent general-purpose am- 
plifier, suitable for phonocardiogram and even 
EEG recording with little or no modification. 
1. 
2. 
3. 
4. 
5. 
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CHAPTER 3 
Sensors and Sensor Attachment 
The bioinstrumentation sensor, as discussed 
in this chapter, includes those sensing elements 
that transduce or transform energy from one 
form to another (such as a temperature-sens- 
ing thermistor), and those devices that make 
energy available for measurement (such as the 
voltage-sensing ECG electrodes). A number 
of major technological advances in bioinstru- 
mentation sensor development and sensor at- 
tachment techniques have resulted from NASA 
spaceflight programs. Particular attention is 
paid in this chapter to ECG electrode con- 
struction details, ECG electrode attachment 
techniques, and E E G  electrode development. 
Additional information is included to il- 
lustrate NASA approaches to other sensor 
problems in bioinstrumentation systems. 
ECG ELECTRODES: DESIGN CONSIDERATIONS 
I n  its simplest form, an ECG electrode con- 
sists of a metal plate contacting the skin 
through a layer of conductive paste. The pri- 
mary requirements of a surface electrode for 
long term monitoring are (1) secure mechan- 
ical attachment and (2) reliable electrical 
contact. 
I n  terms of metal-paste electrode systems, 
these requirements can be met by ensuring 
that (1) the electrode assembly does not be- 
come detached from the skin and (2) the 
conducting paste does not dry. 
Thus, the primary design problems in- 
volve the “electromechanical” configuration of 
the electrode assembly and the adhesive tech- 
niques used to seal it to the skin. There are 
also a number of very important secondary 
design problems affecting the quality of the 
bioelectrical information received from the 
electrodes and the reaction of the subject’s 
skin to the electrodes and attachment sub- 
stances. I f  these problems are not overcome, 
electrical noise can reduce or destroy the use- 
fulness of the signals received; or, discomfort, 
coupled with danger of infection, may require 
the subject to remove the electrodes before 
the end of the mission. More significantly, dis- 
comfort can interfere with his ability to carry 
out assigned tasks during the recording period. 
Included among the secondary design criteria 
affecting signal quality are: 
(1) No electrode polarization ; the electrode 
must exhibit a total reversibility of measured 
potential with a reversal of current. 
(2) Low contact resistance between the 
metallic electrode unit and the living skin sur- 
face. 
(3) No spurious signals generated within 
the electrode assembly during vibration, me- 
chanical contact of spacesuit, etc. 
In addition, on the medical side: 
(1) No damage to the site of electrode ap- 
plication during the recording period. 
(2) No noticeable discomfort while wearing 
the electrode assembly. 
(3) No cumulative toxic effects caused by re- 
peated electrode application; and no delayed 
effects caused by long-term contact. 
These conditions are difficult enough to meet 
for recording under laboratory conditions. 
They become formidable during uninterrupted 
recording periods of several days in spaceflight 
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environments-for example, when the astro- 
naut must remain in his spacesuit, active and 
sweating. 
SPACEFLIGHT ECG ELECTRODES 
when NASA began a development study of 
electrodes for electrocardiographic recording 
in space, many clinical techniques were avail- 
able, each with its particular advantages and 
disadvantages. NASA concentrated on those 
electrode systems that had been developed spe- 
cifically for monitoring the status of active 
subjects. An electrode development program 
was conducted both at McDonnell Aircraft and 
at the NASA Manned Spacecraft Center (ref. 
1). Extensive tests were performed with hu- 
man subjects, and particular attention was fo- 
cused on the skin-to-electrode resistance. The 
results indicated that the fluid-filled eIectrode 
was most readily adaptable for flight use. 
The basic principle of the fluid-filled elec- 
trode is isolation of the electrode from the skin 
by use of a conductive paste to provide the 
skin-to-electrode electrical path. This con- 
figuration greatly reduces spurious signals 
caused by relative movement between the elec- 
trode and the interfacing electrolyte. 
The fluid electrode developed for Project 
Mercury by NASA (shown in fig. 2) consisted 
of a ring of molded RTV silicone rubber that 
supported a disc of 4O-mesh, stainless-steel 
TOP SIDE BOTTOM 
STAINLESS 
STEEL 
SCREEN 
FIGWEE 2,Project Mercury ECG electrolte. 
screen. A piece of small-diameter coaxial cable 
passed through the side of the ring, with the 
central conductor soldered to the screen. After 
application, the electrode formed an open cav- 
ity sealed to the skin (usually with an adhesive 
such as Elastoplast or its equal). Supported 
in the center of this cavity (but not touching 
the skin) was the stainless-steel screen which 
electrically contacted the skin via an electro- 
lyte filling the cavity. After the addition of the 
electrolyte, the open end of the cavity was cov- 
ered with a moisture-proof tape. These elec- 
trodes appeared to give less background noise 
than the standard clinical metal plates. There 
was also less baseline shift when the region of 
attachment was actively moved. 
During the Mercury flights, the monitored 
ECG signal was found objectionably suscep- 
tible to movement artifact (ref. 2) ,  probably 
due to polarization of the stainless-steel-mesh 
electrode. Also, the soldered junction of the 
copper lead to the mesh screen was found to 
cause spurious signals and unwanted noise be- 
cause of electrolytic action of the dissimilar 
materials. Modifications were made to the Mer- 
cury electrode design to circumvent these prob- 
lems for the Gemini flights. 
The improved Mercury electrode (fig. 3) 
was fabricated from a pure silver disc. Holes 
drilled in the disc permitted mobility of the 
electrolyte (achieved with the stainless-steel 
mesh in the Mercury unit). Again, the elec- 
trode lead was soldered to the disc; however, 
the soldered junction in this case was effective- 
ly insulated with a coating of epoxy. After at- 
tachment of the lead, the disc was anodized in 
a solution of sodium chloride to produce a 
thin, smooth coating of silver chloride (ref. 3). 
The RTV silicone rubber electrode housing 
supported the silver disc in a circular groove 
which maintained the disc above the skin. Elec- 
trodes fabricated in this manner were found to 
reduce greatly the noise effects experienced in 
the Mercury flights. This improvement can be 
attributed to the silver-silver chloride disc 
which provides an electrochemically reversible 
(i.e. nonpolarizing) electrode. The epoxy-pro- 
tected solder junction served to reduce spurious 
signals. 
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FIGURE 3.-Improved Mercury ECG electrode. 
Electrodes developed for the Apollo flights 
are markedly different from those developed 
for earlier flights (ref. 4). The more important 
changes include the use of a rigid plastic cup 
to house the silver-silver chloride electrodes 
and the elimination of all soldering. Construc- 
tion details of the Apollo electrode are shown 
in figure 4. Each electrode consists of a Plexi- 
glas type VS 64’7-10 housing, a silver electrode 
disc, a wire lead, and a connector. The silver 
disc is coated with a thin deposit of silver 
chloride, applied by the technique developed 
for the Gemini electrodes. The lead consists of 
a length of clear, 26-gage, Teflon-coated copper 
wire percussively welded to the electrode sil- 
ver disc and the electrode connector. This weld- 
ing process completely precludes lead con- 
I- 1.l25”DIA REF -/ 
EPOXY FILLED 
THERMOFIT 
SLEEVING 
CONNECTOR - PERCUSSIVE WELD 
SILVER DpjC ANOORED 
WITH SILVER CHLORIDE 
3.5” 
FIGUBE 4.-Apbllo ECG electrodes. 
tamination, a situation to be guarded against 
when soldering dissimilar metals. After the 
lead is attached to the silver disc, the disc is 
sealed to an inner shoulder of the electrode 
housing, and the top cavity is filled with epoxy. 
This encapsulates the backside of the disc, the 
wire junction, and a short length of the lead 
wire. The result is an electrode which is elec- 
trically reversible (i.e. nonpolarizing) , rugged, 
small, and much easier to apply than the Mer- 
cury and Gemini electrodes. 
ELECTRODE PASTE 
After many investigations of standard ECG 
electrode pastes, NASA determined that the 
hypertonic nature of these electrolytes (having 
a greater osmotic pressure than the skin) 
caused objectionable irritation when applied 
for more than about 24 hours. Consequently, 
NASA developed a paste for the Mercury pro- 
gram that produced no irritation after more 
than 48 hours of use. I n  addition, it was slow- 
drying, had a high viscosity, and would main- 
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tain electrical resistance stability. The paste 
was a modified bentonit8 compound (alumi- 
num silicate powder) consisting of 15 grams 
6f bentonite, 10 cc of water and 3 grams of 
calcium chloride, and was used on the early 
Mercury flights (ref. 1). 
Ldter Mercury flights used ft further re- 
finement, a 10-times isotonic concentration of 
ers' physiological solution, thickened with 
Carbopo1.l This paste also includes 0.1 percent 
propyl-p-hydroxybenzoate as a preservative 
to prevent deterioration from biological con- 
tamination. Subsequently, the thickening agent 
was changed from Carbopol to a mixture of 
Natrosolp and PVP; which simplified formu- 
lation of the paste and provided a nonirritat- 
ing, lionsensitizing electrolyts. These pastes 
were tested on more than 50 subjects with ap- 
plication times up to 7 days (ref. 5) and were 
found to be completely compatible with the 
long-term monitoring requirements of the 
Gemini and Apollo missions. 
ECG ELECTRODE APPLICATION 
An improved method for applying the 
NASA EGG electrodes was evolved during 
Project Mercury, and excellent results were 
obtained using this technique for attachment 
and sealing. The procedure, if performed by 
an experienced technician, allows attachment 
of the Mercury and Gemini-type electrodes in 
about 3 minutes. 
The skin is first lightly swabbed with ace- 
tone or an ether-acetone mixture. (Any unde- 
sirable hair is removed by shaving, using care 
not to damage the skin.) A ring of Stomaseal 
tape is applied to the flange of the electrode 
housing. The electrode is then filled with elec- 
trode paste from the front (using care not to 
get paste on the tape or the back of the hous- 
ing) and pressed to the cleansed skin. Next 
' Carbopol 940 (B. F. Goodrich). 
Hydroxy-ethylcellulose-Natrosol 2.50 HR (Hercules 
Powder Co.) . 
* Polyvinyl pyrrolidone K-90 (General Aniline 
Gorp.). 
' Washer-shaped, double-xided adhesive mounting 
discs cut from Scotch No. 1500 Stomaseal (Colostomy) 
tape. 
the back of the electrode housing is filled with 
paste and the opening covered with a 1-inch 
square of Mystic tape. A %inch square of Mi- 
cropore6 is then applied to cover the entire 
electrode after the electrode lead is dressed to 
the desired position. Electrode resistance will 
vary at application from about 100 to 5 kilohms 
and will drop in approximately 1 hour to 50 to 
2 kilohms. I f  extremely low electrode resistance 
is required, the technique of decornification or 
skin drilling (ref. 6) may be used to provide 
resistances of 1 to 5 kilohms, which will re- 
main at  this level for at least 48 hours. Upon 
removal of the electrodes, the skin is washed 
with Zephyran chloride and an antiseptic skin 
lotion applied to prevent irritation or infec- 
tion. 
The procedure for applying NASA's Apollo 
electrodes is somewhat different in that the 
paste filling is done in one step instead of two. 
Since the Apollo electrode has an open front 
and closed back, the electrode is filled approxi- 
mately two-thirds full after the Stomaseal is 
applied to the electrode. Then the electrode is 
pressed to the skin and covered with a 3-inch 
diameter piece of Micropore tape. (The closed 
back eliminates the need for the Mystic tape.) 
ECG ELECTRODE PLACEMENT 
Choice of the anatomical sites for ECG elec- 
trode placement was made by NASA after ex- 
tensive investigations of the ease, convenience, 
validity, and reliability of signal sensing for 
various lead configurations (ref. 7 ) .  
The original Project Mercury ECG elec- 
trode scheme included three electrodes for 
two EGG leads, with one electrode common to 
both measurements. However, to make both 
measurements completely independent, the 
three-electrode system was changed to four. 
The electrode sites chosen are illustrated 
in figure 5; they were the bilateral mid-axil- 
lary line (electrodes 1 and 2) and the anterior 
midline of the episternal area (electrodes 3 
and 4). The axillary lead consisted of one elec- 
trode placed at  the base of the rib cage on the 
' Mystic Silicone Tape No. 7010. 
Scotch Micropore Surgical Tape No. 530. 
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electrodes. 
right side with the left electrode placed on 
the rib cage at the third intercostal space. The 
sternum lead was roughly at right angles to 
the axillary lead, with one electrode placed on 
the manubrium and the other at the xiphoid 
process. The choice of these sites was based 
on the following factors: 
(1) The sternum has very little underlying 
muscle tissue and thus reduces the possibility 
of electromyographic artifact effects. 
(2) The intercostal (rib) muscles also gen- 
erate very small electromyographic potentials, 
even with rather violent activity. 
(3) The data from these two lead configura- 
tions correlate very well with traditional data 
from standard ECG leads. 
The axillary lead was found to be addition- 
ally useful when, in later Gemini flights, the 
impedance pneumograph was used for extract- 
ing respiration data. The impedance pneumo- 
graph requires one set of electrodes across the 
thorax at the mid-axillary line, and at the 
sixth or seventh intercostal space. Develop- 
ment of compatible electronics allowed the im- 
pedance pneumograph and ECG amplifier to 
share the same set of electrodes. Hence, minor 
relocation of the axillary electrode pair permit- 
ted two completely different physiological 
measurements to be made simultaneously from 
the same set of electrodes. 
EEG ELECTRODES 
NASA is currently engaged in the develop- 
ment of an improved system for obtaining the 
EEG of pilots and astronauts performing 
tasks under stress. I n  most applications, EEG 
electrodes have been cemented to the scalp; 
they are uncomfortable, irritate the scalp, and 
take as long as an hour to attach. This tech- 
nique was used on pilot Frank Borman on the 
Gemini VI1 mission. The electrodes consisted 
of chlorided silver discs imbedded in small 
plastic cups. The cups were filled with an elec- 
trode paste and attached to the scalp with 
Eastman 910 adhesive over sites which had first 
been denuded with depilatory cream and light- 
ly drilled with a high-speed dental burr to 
break the skin surface (ref. 8). 
I n  addition to the problem of comfort and 
the time-consuming attachment technique, 
these electrodes also required that the lining 
material of the astronaut’s helmet be designed 
with indentations to avoid pressure on the elec- 
trodes. The flight data showed that good qual- 
ity EEG tracings were obtainable with this 
technique for relatively long periods of time. 
(One of the two EEG channels provided some 
useful data up to the 54th hour of flight; ref. 
8.) However, in summarizing the EEG ex- 
periment of the Gemini VI1 flight, Maulsby 
states that ((it is hoped that a longer-lasting 
electrode system can be developed in the near 
future . . .” (ref. 9). 
A novel EEG electrode system, which con- 
sists of nonirritating sponge-type electrodes 
mounted in the subject’s helmet, shows promise 
of meeting this aim. The main development ob- 
jective is to produce an electrode confguration 
that can be put on and removed by the astro- 
naut in the course of donning and removing 
his helmet without any special attachment to 
the scalp or parting or removal of hair. Early 
investigations of the sponge-type EEG were 
conducted, partially under NASA support, 
at the UCLA Brain Research Institute (ref. 7) 
and resulted in the configuration shown in fig- 
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FIGURE 6.-Early helmet-mounted sponge electrode and preamplifier system, developed at 
the Brain Research Institute, UCLA. 
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ure 6. Preamplifiers in the form of small cylin- 
ders were imbedded in the helmet liner. A 
short input lead made connection with a stain- 
less-steel wire, which, in turn, contacted a 
sponge soaked in a nonirritating electrolyte. 
A silicon rubber grommet was molded to fit 
an aperture in the liner and served to preserve 
the liquid. When the liner was placed on the 
head with no preparatory cleansing of the 
scalp, satisfactory contact developed within 
a few minutes. The contact developed more 
rapidly if electrode paste was lightly applied 
to the scalp, but this was not essential. 
Further developments by the Brain Research 
Institute produced the electrode system shown 
in figure ‘1. The configuration is unique in that 
a simple tin electrode in a stannous chloride 
electrolyte eliminates the common problem of 
electrolyte-metal movement artifact. The elec- 
trolyte and tin electrode are encased in a semi- 
permeable ceramic shell which is, in turn, sur- 
rounded by the scalp-contacting sponge mate- 
rial (A). The ceramic cups are prepared by 
machining commercially available hydrous 
magnesium silicate rods to the required dimen- 
sions and then firing to the desired hardness. 
An epoxy flange is molded in place onto the 
cylindrical cup. A separately molded silastic 
rubber cap is used to hold the tin wire in place 
r LEAD r RissER FLANGE 
COMPLETED 
ELECTRODE 
UNIT 
F X G ~ E  ?.-Improved BRI helmet-mounted EEG 
electrode. 
inside the cup (B) . Contact between the scalp 
and the electrode is established by a cylindrical 
cellulose acetate sponge, which is hollowed at 
one end to accept the ceramic cup assembly (C) 
and (D). The sponge is housed in a silastic 
rubber flange assembly, which provides a 
means of attaching the electrode to the helmet 
and serves to contain the electrolyte in the 
sponge. The sponge protrudes about 7 mm 
from the flange to ensure good cont?,A with the 
scalp. It is wetted with a physiologically com- 
patible electrolyte such as saline, $$ N KCL or 
Ringer’s soluLion containing polyvinyl-pyrroli- 
done as a thickening agent. No special prepara- 
tion of the scalp is required, except for the re- 
moval of oils from the hair and skin at the con- 
tact site. NASA is currently supporting7 
further development of this type of electrode 
with an integrated preamplifier for use in the 
Apollo program. 
A similar concept in sponge-type electrodes 
has been developed by NASA at its Ames Re- 
search Center (ref. 10). The Ames electrodes 
are part of a complete EEG telemetry system 
mounted entirely in a flight helmet. The system 
includes amplifiers, a battery-powered wireless 
transmitter, and the sponge-type electrodes. 
The sponge electrode (fig. 8) consists of a flex- 
ible tip resting against the scalp and a rigid 
section that fits securely in the helmet. The 
flexible portion is a hollow-core cellulose ace- 
tate sponge impregnated with electrode paste. 
The rigid portion consists of a disc of fritted 
glass wetted with a saline solution, a disc of 
compressed silver powder, a disc of Ag-Ag-C1, 
and a solid-silver amplifier contact. The cylin- 
drical sponge portion of the electrode is slight- 
ly compressed when fitted to the subject; this 
provides light, steady compliance with the 
scalp. Except for the tips, the exterior of the 
sponge is coated with a thin layer of self-level- 
ing silicone rubber. One of the tips extends 
6 mm to contact the scalp. The rubber coating 
helps to retain moisture within the sponge; 
it also provides a small degree of stiffness SO 
that the sponge can penetrate the hair. The 
sponge portion of the electrode system is dis- 
posable after use. 
7.Contract NAS 9-7832. 
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FIGURE 5.-Construction details-NASA/Ames helmet- 
mounted EEG electrode. 
Extensive tests of this electrode system have 
been made during the last 2 years at NASA/ 
Ames, including laboratory tests and tests on 
jet aircraft flights and centrifuge runs. These 
tests have demonstrated the feasibility of the 
concept. After one of the centrifuge runs, the 
subject was asked to remove his helmet for 5 
minutes. Tests were resumed without making 
any adjustments to the helmet or to the elec- 
trodes, and there was no loss of data. 
A D D I T I O ~ L  CONT 
BODY TEMFE~TURE SENSORS 
NASA used two different types of body tem- 
perature sensors in the Mercury program: a 
rectal probe incorporating a thermistor sensing 
unit; and, later, a skin temperature probe con- 
, sisting of a thermistor in a thermoinsulated 
disc (fig. 9). Both of these units were de- 
veloped in NASA facilities. The rationale for 
using the rectal probe on Mercury flights and 
the results obtained are discussed in chapter 2 
and reference 1. 
FIOWE 10.-Oral temperature sensor used in the 
Gemini flights. 
For the Gemini flights, an oral temperature 
sensors (fig. 10) was substituted for the rec- 
tal probe (ref. 2). This sensor consisted of a 
finger-formable Teflon-covered thermistor as- 
sembly attached to a small section of machined 
polycarbonate. The polycarbonate section con- 
tained a Velcro pad for easy attachment in- 
side the astronaut's helmet. Preliminary tests 
showed it was difficult to hold the probe in the 
mouth because of the small probe diameter and 
the slick Teflon cover. This problem was elim- 
inated by slipping a 5/32-inch diameter Neo- 
prene sleeve over the Teflon-covered probe, 
leaving approximately % inch of the Teflon 
exposed. Used with appropriate signal con- 
ditioning equipment, this oral temperature 
'Developed for NASA by Spacelabs, Inc., Van Nuys. 
SENSORS 23 
probe covers the range of 9 5 O  to 1 0 5 O  F with 
an ,accuracy of 0.05 percent. 
A new skin temperature sensor (fig. 11) was 
developed for the simulation chamber bioin- 
strumentation system used in the Apollo pro- 
gram (ref. 4). This sensor consists of a therm- 
istor mounted at the center of a plastic sup- 
port which serves to hold the thermistor 
against the skin with moderate pressure, pro- 
vide good protection for the thermistor, and 
ensure ventilation and accurate skin tempera- 
ture sensing. It is normally attached to the 
skin with a Stomaseal ring. Temperature meas- 
urement range is 80’ to 1 1 5 O  F+0.3’ using 
compatible electronics. 
APPLICATION EVALUATION 
NASA bioinstrumentation sensors and sen- 
sor attachment techniques have resulted in 
many technological advances which have di- 
rect applicability to clinical and research medi- 
cine. For example, the NASA-type electrode 
housing and attachment techniques have 
already been accepted by the medical commu- 
nity as a significant advancement in electrode 
technology. Various manufacturers offer a var- 
iety of electrode sizes and shapes based on 
NASA-initiated developments. 
FIGUBE 11.-Skin temperature sensor-Apollo space 
chamber simulation. 
This transfer of NASA technology will un- 
doubtedly continue because of the increasingly 
frequent use of bioinstrumentation for clinical 
patient evaluation and monitoring, and for 
medical, physiological, and psychophysiologi- 
cal research. ECG and EEG measurements are 
more and more becoming a diagnostic and an 
evaluative tool of the clinician. Consequently, 
the demands placed on the measuring devices 
have increased tremendously in terms of relia- 
bility, longevity, and patient comfort. NASA’s 
improvements to sensor technology aid ap- 
preciably in meeting these demands. I n  its 
electrode fabrication, NASA has had to be ex- 
tremely sensitive to such phenomenon as con- 
taminant “out-gassing” at very low pressures, 
flammability in pure oxygen atmospheres, and 
the like. The resultant narrowing of material 
choices, in addition to the rigorous quality con.- 
trol procedures imposed on all space-qualified 
equipment (see chapter 8), naturally makes the 
NASA component expensive. But by relaxing 
those NASA restrictions that go far beyond 
normal medical needs, the functional improve- 
ments achieved by NASA over conventional 
sensors may be advantageously incorporated 
by the medical community at reasonable cost. 
REFERENCES 
1. WHEELWRIGHT, C. D. : Physiological Sensors for 
Use in Project Mercury. NASA TN D-1082,1962. 
2. HENRY, J. P ;  AND WHEELWRIGHT, C. D.: Bioin- 
strumentation in MRA Flight. Proceedings of a 
Conference on the Results of the First U. S. 
Maimed Suborbital Spaceflight, June 6, 1961, 
pp. 37-43. 
3. DAY, J. L.; AND LIPPITT, M. W.: A Long-Term 
Electrode for Electrocardiography and Imped- 
ance Pneumograph. Psychophysiology, vol. 1, 
Oct. 1964, pp. 174-182. 
4. Spacelabs, Inc. : Apollo Bioinstrumentation. Final 
Rep., Contract NAS 44022, Rep. SR66-1035, 
July 1966. 
5. LIPPITT, M. W. : Personal communication. NASA/ 
MSC, July 18, 1963. 
6. SHACKEL, B. : Skin-Drilling : A Method of Dmin- 
ishing Galvanic Skin Potentials. Am. J. Psych., 
vol. 72, 1959, pp. 114-117. 
7. ADEY, W. R. ; WINTEBS, W. D.; KATO, R. T.; AND 
DELUCCHI, M. R. : EEG in Simulated Stresses of 
24 B I O I N S T R ~ N T A T J . O N  SYSTEMS 
Spaceflight With Special Reference to 
of Vibration. Electroenceph. CLin. Neu 
ncephalogram During 
. Med., vol. 37, no. 10, Oct. 
ts Electroencephalograms 
Brief 66-10536, Nov. ference, Feb. 23-25, 19 
423-429. 
I n  a bioinstrumentation system, the signal 
conditioner operates betwen the primary sensor 
and the processing and display units. Figure 
12 illustrates the location of the signal condi- 
tioners in the Gemini safety bioinstrumenta- 
tion system; the general arrangement is simi- 
lar in most laboratory and clinical systems. 
Frequently, the signal conditioner is the “for- 
gotten” element of the system. Sensors, trans- 
ducers, and computation and display tech- 
niques generally offer the more obvious and 
intriguing design problems, leading to relative 
neglect of the intermediate conditioning func- 
tion. Nevertheless, signal conditioning is fun- 
damentally important because the signal con- 
ditioner largely determines the form of the 
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FIGWE 12.-Gemini safety bioinstrumentation system 
-one astronaut. 
CHAPTER 4 
Signal Conditioning 
25 
biomedical information supplied to the system 
user, directly influencing his concept and inter- 
pretation of the underlying physiological proc- 
esses. 
For example, early ECG recordings con- 
tained a broad baseline composed of 60-Hz 
noise. Physicians became accustomed to its 
presence, unconsciously accepting it as part of 
the signal. When improvements in signal con- 
ditioners eliminated this noise source, the 
“clean” ECG complex was rejected in several 
instances because it did not resemble textbook 
examples. However, the clean signal soon 
brought about greater appreciation of detail in 
the ECG waveform. This led to further im- 
provements in signal conditioning, expanding 
the signal frequency bandwidth. Attention was 
then focused on other limiting elements in the 
system, such as the strip chart recorder. The in- 
adequacies of this output unit promoted com- 
puter analysis of the ECG signals and rein- 
forced what has become a major movement 
in clinical medicine. 
I n  a more general sense, the designer must 
decide what is useful signal and what is noise 
at the level of the signal conditioner, partic- 
ularly with respect to signal frequency com- 
ponents. The distinction between signal and 
noise is not always obvious. Often it is forced 
by bandwidth restrictions that act along with 
other interface constraints to shape signal con- 
ditioner design. This has been the case in 
NASA spaceflight. Only limited bandwidth is 
allowed the biotelemetry channels, and it must 
be apportioned among the various physiologi- 
cal signals. In fact, the bioinstrumentation 
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bandwidth allocation has decreased constantly 
from the Mercury to the Apollo programs, re- 
flecting increased confidence of medical well- 
being in spaceflight and more efficient use of 
bandwidth. The reduction has necessitated a 
continual reevaluation of critical signal fre- 
quencies for each physiological signal source. 
Even when bandwidth is not critical, the cir- 
cuit designer attempts by filtering or other 
means to minimize noise and artifact, and per- 
haps to accentuate certain crucial aspects of 
the biomedical signal. His design rests on basic 
knowledge of the origin of the signal and 
awareness of its subsequent utilization in the 
system. Design conventions may change as new 
knowledge is gained; or a previously accept- 
able design may be reworked to meet new sys- 
tem requirements. For example, the optimum 
frequency range for the brachial pulse signal 
in automatic ausculatory blood pressure meas- 
urement is still an open question. And the 
change from a differential low level (10 MV) 
multiplexer on Gemini spacecraft to a single- 
ended high level (5V) unit on Apollo neces- 
sitated extensive circuit redesign of equivalent 
bioinstrumentation signal conditioners. 
The functional boundaries of the signal con- 
ditioner can be difficult to define. The basic sig- 
nal conditioner consists only of amplifiers and 
filters. In  other cases it may include some eom- 
putational elements, or serve as a telemetry 
transmitter. NASA spaceflight signal condi- 
tioners have been primarily the basic type, 
preparing the biological signal for telemetry 
(or onboard recording) and ground process- 
ing. As is shown in figure 12, the signal condi- 
tioners themselves are small separate packages 
worn by the astronauts under the spacesuit in 
a compartmented belt. Figure 13 shows the 
spaceflight units for Gemini along with the 
electrical harness assembly. Other NASA re- 
search, not%bly in the biotelemetry field, has 
led to development of highly advanced signal 
conditioners performing several functions in 
the bioinstrumentation system. 
The three major examples presented in this 
chapter were chosen to illustrate distinct facets 
of signal conditioner design shared by NASA 
and nonaerospace programs. The units de- 
FIGUBE 13,Harness assembly for the Gemini signal 
conditioners. 
scribed are representative of specific problem 
areas in bioinstrumentation system develop- 
ment : (1) meeting rigorous performance speci- 
fications, (2) making a difficult measurement, 
and (3) providing sophistication along with 
miniaturization. 
APOLLO ECG SIGNAL CONDITIONER 
The Apollo ECG signal conditioner repre- 
sents a system element designed to accomplish 
a well-defined task under exacting measure- 
ment conditions. It is the latest of #three succes- 
sively improved units supplied in turn for the 
Mercury, Gemini, and Apollo programs. 
Early in its planning, NASA determined the 
requirements for electrocardiogram (ECG) 
signals from its astronauts in space (see chap- 
ter 2). These measurements, however, required 
almost entirely new equipment. Clinical meas- 
urements are typically made for only short 
periods in a stable environment on almost im- 
mobile patients. The clinician usually has di- 
rect access to the equipment and to his patient 
and could make adjustments or ask for sub- 
ject cooperation during the recording session. 
Measuring active subjects continuously for 
Developed and fabricated for NASA by Spacelabs, 
Inc. 
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days and weeks in a spacecraft posed formi- 
dable problems. These were compounded by 
the need for the equipment to operate without 
adjustment. 
I n  principle, ECG signal conditioning in- 
volves nothing more than amplification of a 
varying voltage obtained from surface elec- 
trodes. Ideally, the conditioner should amplify 
the signal without altering its characteristics 
while guarding against spurious signals, such 
as environmental interference and circuit noise. 
Noise from all sources may be reduced by lim- 
iting the band of frequencies over which the 
amplifier functions, taking care not to elimi- 
nate valuable components of the ECG signal 
itself. These steps do not reduce noise in the 
frequency band of the signal, nor affect the in- 
troduction of “unwanted” voltages from elec- 
trode movement or from extraneous fields. 
The sensors, the input leads, and even the 
subject’s body may act as receiving antennas 
for the electrical and magnetic fields estab- 
lished by conductors carrying alternating cur- 
rent within the spacecraft. Two remedies may 
be employed to reduce the pickup effect: (1) 
shielding the input leads ; and (2) using input 
circuitry which discriminates against un- 
wanted signals. NASA’s greatest contributions 
to the technology of signal conditioners for 
electrocardiography lie in the area of noise 
discrimination. 
Figure 14 depicts schematically the Apollo 
signal conditioner’s three differential amplifi- 
ers (ref. 1). Specifications call for an input 
impedance of greater than 40 megohms, a com- 
mon mode rejection (CMR) ratio of greater 
than 100 000 :1, a continuously variable gain 
of 600 to 4500, and an input noise level less 
than 5pV peak-to-peak. Both high input im- 
pedance and high common mode rejection are 
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FIGWEE l4.-Apollo EGG signal conditioner-block 
diagram. 
extremely important to noise elimination, and 
both are unusually high in the Apollo uniL2 
Figure 15 shows in detail how thqse high 
performance specifications were achieved in 
the preamplifier circuitry. The schematic 
a1 amplifier stage comprised 
of the dual transistors &l, &2, and &3. These 
transistors, in effect, operate as two single tran- 
sistors with an overall current gain ( p ) ~  ap- 
proximating the product of the current gain 
of each of the three transistors (p)3.  This mul- 
tiplication effect is reflected as an extremely 
high input impedance, which is negligible com- 
pared to the resistive network of R1, R2, and 
2325. These resistors then determine the input 
impedance, which is greater than 40 megohms. 
The emitter circuits of the groups-of -three 
(&1A-&2A-&3A, etc.) are fed by constant 
current sources &5A and &5B, which serve in 
differential amplifier stages to increase the 
common mode rejection ratio and balance off- 
set drifts. The 100-db common mode rejection 
ratio is achieved by careful matching of com- 
ponent characteristics. Minute variations in 
transistor properties exist, especially at the low 
collector currents in the preamplifier. These 
variations could have been balanced through 
inclusion of a potentiometer but, because of 
size and weight restrictions, the compensation 
was done by component selection. The pack- 
aging technique, required to fit the complex 
circuitry of the ECG signal conditioner in the 
small Apollo module container and to meet 
a The input impedance of an amplifier is the ratio of 
the amplitude of the input voltage to the resultant 
current flow in the input circuit. The input voltage is 
developed across the input impedance and is at a maxi- 
mum when the source impedance is negligibly low in 
comparison to the amplifier input impedance. There- 
fore, if the input impedance is not sufficiently high, 
attenuation and distortion of the recorded voltages 
may occur. Also, changes in the source impedances can 
be reflected as apparent output signals. In EGG meas- 
urements the source impedance is a function of the 
type of electrode used, and it is common to experience 
source impedance variations of thousands of ohms. 
The CMR of a differential amplifier is a figure of 
merit for reduction of in-phasehput signals caused by 
electrical field interference over out-of-phase signals 
caused by biological phenomenon. The greater the 
GMR, the greater the discrimination against extrane- 
ous noise. 
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simultaneously the rigorous environmental 
specifications, is described in chapter 8. 
GEMINI BLOOD PRESSURE SIGNAL 
CONDITIONER 
This section describes the spaceflight signal 
conditioner used to obtain indirect arterial 
blood pressure measurements during Gemini 
flights.3 The design task was somewhat like 
that for the EGG unit in that a common clini- 
cal measurement had to be obtained under dis- 
advantageous conditions. But in many respects, 
blood pressure measurement represented a 
more novel problem because the definition of 
indirect arterial pressure is not as well estab- 
lished as that of the ECG and because pneu- 
matic and acoustic energies, along with electric 
signals, are involved in blood pressure meas- 
urement. 
The value of arterial blood pressure as a 
summary cardiovascular measure is well 
known. Physiologists for many years have rou- 
tinely measured the pulsatile arterial pressure 
at  a number of sites by direct arterial puncture. 
While direct recording is ideally suited for ex- 
perimental animals or humans under aseptic 
hospital conditions, its use in routine clinical 
examination is unacceptable. Instead, indirect 
sphygmomanometry is used. This method 
utilizes a pneumatic occluding cuff on the up- 
per arm and a stethoscope or microphone 
downstream over the brachial artery. The cuff 
is inflated until flow in the artery is stopped 
and is then slowly deflated. Cuff pressure at  
the first appearance of sounds (called Korot- 
kow sounds) over the artery is taken as systolic 
pressure (the highest pressure in the cyclic 
arterial pressure waveform). Cuff pressure 
when the sounds disappear is generally ac- 
cepted as diastolic pressure (the trough of the 
arterial wave). Determination of these points 
requires some observation skill. While indirect 
sphygmomanometry yields only a small frac- 
tion of the information contained in a continu- 
ous record of arterial pressure, the great mass 
of clinical data obtained over the last 50 years 
provides a solid statistical basis for its use. 
I n  the Mercury and Gemini programs, 
NASA decided to use indirect sphygmoman- 
ometry as the simplest and most practical 
method for obtaining a useful measure of 
arterial blood pressure in flight (ref. 2). 
Absence of a skilled observer or visual display 
devices required the pressure and sound infor- 
mation to be transmitted to ground stations for 
interpretation. With Gemini, the measurement 
was accomplished using the following com- 
ponents : 
(1) An arm cuff specially designed for oper- 
ation beneath the pressure suit. 
(2) An inflation assembly consisting of a 
manually operated squeeze bulb and a bleed 
orifice to impose a constant cuff deflation rate. 
(3) A microphone assembly consisting of a 
piezoelectric crystal and integral preamplifier. 
(4) A signal conditioner containing the cuff 
pressure transducer and amplifier, a Korotkow- 
sound amplifier, and the circuit for mixing the 
dc pressure signal with the ac pulse signal. 
Automatic cuff inflation devices had been 
planned but were not installed on the Mercury 
vehicle. Manual cuff inflation provided econ- 
omy and reliability in the Gemini system. As 
pointed out in chapter 2, the Mercury and 
Gemini bioinstrumentation electronics were 
housed in the space capsule instead of within 
the space suit. 
Figure 16 is a diagram of the Gemini flight 
system. Operation of the cuff was similar to 
the standard clinical device. Cuff pressure was 
measured by a pressure transducer, which 
II I 
- WTPUT MICROPHDNE SIGNAL CONDITIONER 
Developed and fabricated by the AiResearch Divls- 
ion of the Garrett Gorp. 
FIGUBE 16.-Gemini arterial blood pressure measure 
ment-block diagram. 
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yielded a proportional dc output signal. At  
the appearance of the first Korotkow sound, 
an ac signal was superimposed on the dc out- 
put. The pressure corresponding to this first 
sound was taken as systolic arterial pressure. 
As the cuff deflated further, the sound signals 
increased in amplitude, then decreased until 
they finally disappeared. The pressure corre- 
sponding to the last observed sound was taken 
as diastolic arterial pressure. The trace on the 
right-hand side of figure 16 illustrates a typical 
recording produced by the system. 
Figure 17 shows details of the Gemini blood 
pressure signal conditioner itself. Three ma- 
jor contributions to bioinstrumentation design 
were : 
(1) Hiniature pressure transdzccer. NASA 
supported an intensive effort by AiResearch 
Gorp. to develop a solid-state semiconductor 
strain-gage pressure transducer (ref. 3). 
(2) Korotkow sotmd filtering. The Korot- 
kow sounds are processed by a narrowband 
filter in the Gemini system. According to its 
designer, the sound components between about 
30 and 40 Hz undergo more clearly defined 
changes in amplitude when the arterial flow is 
occluded. Thus at  these frequencies, the end 
points of the Korotkow sounds correspond 
more closely to systolic and diastolic arterial 
pressures. 
(3) Packaging. A unique part of the design 
is the packaging of the cuff pressure transduc- 
er within the small (approximately 1.35 cubic 
inch) volume of the signal conditioner. A small 
tubular extension of the signal conditioner at- 
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' FXOUBE 17.-Partial assembly-Gemini blood pressure 
signal conditioner. 
taches to the cuff pressure line. A reference 
port admits suit pressure to one side of the 
strain gage transducer diaphragm to provide a 
gage reference. This addition was necessary 
because cabin pressure can change markedly 
during spaceflight. 
Additional contributions included the elimi- 
nation of one of the two amplifier filter sec- 
tions in the pulse channel that had been re- 
quired for Project Mercury. Moreover, the 
circuik was modified to reduce the required 
dynamic range of the gain control, its adjust- 
ment being virtually foolproof. The results of 
these improvements were a large savings in 
weight, size, and power consumption over the 
Project Mercury system. Specifications for the 
Gemini unit are shown in table 4. 
TABLE .l.--Xignal Conditioner and 
Microp hoiw 
Parameter Value 
Output ac section 
Output de section 
lBmY peak-to-peak pulse 
0 to 20 mV corresponding to 
50 and 250 mm Hg; linear 
within 1% ; accuracy 1% 
Output impedance 5000 ohms maximum 
Power requirements 170 milliwatts maximum 
Size 1.5X2.0X0.375 inches maxi- 
mum 
Weight 43 grams maximum (signal 
conditioner) 
20 grams maximum (micro- 
phone and preamplifier) 
The final flight configuration represents a con- 
siderable advance in semiautomatic sphygmo- 
manometers. It is small, lightweight and ca- 
pable of operating in a noisy environment. 
IMPLANT BIOTELEMETRY 
Implant biotelemetry is recognized as one 
of the best means to obtain continuous internal 
physiological data without restraining the 
subject. Animal instrumentation for the Bio- 
satellite program as well as a basic interest 
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in physiological phenomena has led NASA to 
investigate implant biotelemetry. Study of f ac- 
tors such as circadian rhythm requires continu- 
ous stable data acquisition over long periods 
of time. Advancing the state-of-the-art in this 
field assists in the general study of physiologi- 
cal responses to long flights and extraterrestri- 
al environments. 
Implant telemetry differs little from other 
telemetry systems. Biopotentials are picked up 
inside the body by sensors and amplified by a 
signal conditioner which modulates the trans- 
mitter. The transmitter radiates energy to an 
external receiver where the original signal is 
reconstructed and displayed. However, oper- 
ation within an organism imposes novel re- 
quirements of sterility, physiological and 
psychological reactivity, size, stability, power 
level, and reliability. 
NASA’s activity in the field has resulted in 
several independen6 developments which have 
brought about a variety of solutions to the 
problems of implant biotelemetry. Develop- 
ment work has been done at the NASA Ames 
Research Center (refs. 4 through ll), the 
Space Sciences Laboratory, University of 
California, Berkeley (refs. 12 and 13), and the 
Department of Engineering, Case Institute of 
Technology (refs. 14, 15, and 16). 
R. S. MacKay, while at  the Space Sciences 
Laboratory, Berkeley, established some funda- 
mental design criteria for implant biotelem- 
etry. Requirements of small size and weight, 
high reliability, and low power drain have 
given impetus to the development of simple 
circuits in which the functions of sensor, signal 
conditioner, and transmitter are closely inte- 
grated. A circuit developed by MacKay (refs. 
12 and 13) using this approach is illustrated in 
figure 18. Only one transistor is used in order 
to reduce power drain. The versatility of such 
a circuit is notable. Temperature can be meas- 
ured by replacing the resistor R with a therm- 
istor. Pressure can be measured by allowing 
pressure changes to move the core M. By at- 
taching suitable electrodes across the input X- 
P; other variables, among them pH, can also 
be recorded. 
X Y 
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FIGUBE 18.-Simple biotelemetry transmitter circuit 
developed at the Space Sciences Laboratory, Univer- 
sity of California, Berkeley. 
Such common biotelemetry circuits do not 
always meet rigorous performance specifica- 
tions. Several fundamental limitations are : 
(1) Variations in supply voltage introduce 
large errors 
(2) Input impedance generally low 
(3) Gain and frequency sensitive to temper- 
(4) Range of frequency response and sen- 
( 5 )  Power consumption high. 
T. €3. Fryer and his colleagues at the NASA 
Ames Research Center have developed sophis- 
ticated circuits that circumvent the above lim- 
itations. By using advanced microelectronic 
circuit elements, such as high-quality silicon 
transistors, and by employing high-density 
packaging techniques, circuit sophistication 
was greatly increased without a corresponding 
increase in size. 
An implantable microwabt transmitter (refs. 
10 and 11) which accurately measures and te- 
lemeters deep body temperature for periods up 
to 2 years illustrates how electronic advances 
ature 
sitivity inadequate 
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FIGWE 19.-Miniature biotelemetry transmitter developed at NASA/Ames for temperature measurement. 
have been applied by NASA Ames Research 
Center to improve miniature implantable de- 
vices (fig. 19). The information transfer in 
this telemetry scheme is by means of pulse code 
modulation. The solid-state switch is a bistable 
multivibrator which periodically samples 
(chops) the continuous signal from the therm- 
istor (T) in order to save power. The therm- 
istor signal and precision resistor E7 control, 
in turn, the spaces between successive 15-micro- 
second pulses of the astable multivibrator. The 
interval between pulses varies from 8 to 20 
milliseconds as the temperature being moni- 
tored varies from 45' to 35' C.  The signal 
from the astable multivibrator activates the 
radio frequency (RF) oscillator. 
Transistor &7 functions as a frequency 
modulated R F  oscillator, as well as a transmit- 
ter, while inductor L serves as a tuning coil, 
and as the transmitting antenna. Temperature 
informath  is available as the time period 
between R F  pulses. Inherent compensatory 
provisions in this circuit, based on the relation- 
ship of the thermistor to the precision resistor- 
controlled pulse intervals, reduce the detri- 
mental effects caused by battery voltage fluc- 
tuations, transistor drift, or other component 
instability. This insensitivity to extraneous 
forces is a significant feature, since it allows 
the use of miniature components with less crit- 
ical specifications. Differential temperature 
measurements can be obtained by replacing 
the precision resistor R7 with another thermis- 
tor. The circuit can easily be modified for 
telemetering other physiological variables, 
such as pressure measurements (ref. 5), or bio- 
potential measurements (ref. 6). 
Figure 20 illustrates the internal construc- 
tion details of a pressure telemetry implant 
developed at  NASA/Ames. Figure 21 shows 
one method of miniature component assembly 
developed by NASA/Ames, in this case for a 
biopotential transmitter. There is a clear re- 
semblance between this assembly technique and 
the "stacked cordwood" construction utilized 
in flight signal conditioner fabrication (see 
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FIGWE 20.-Exploded view-NASA/Ames implantable 
pressure telemetry syscem. 
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FIGURE 21.-Component assembly-NASA/Ames im- 
plantable biopotential transmitter. 
chapter 8). When one remembers that the 
flight signal conditioners are approximately 
100 times the size of the biotelemetry implants 
and yet perform for fewer functions, the de- 
sign difficulties of the implant units become 
apparent. 
W. H. KO and his group at the Case Insti- 
tute of Technology have specialized in biote- 
lemetry circuits incorporating newer develop- 
ments, such as tunnel diodes, backward diodes, 
and varacap diodes, as well as microelectronic 
techniques (refs. 14, 15, and 16). Two versions 
of biopotential transmitter circuits, utilizing 
tunnel diodes as the main active elements, are 
shown in figure 22. In  Model K-1, the bias of 
the oscillator tunnel diode is varied to fre- 
quency modulate the carrier signal. 
Model K-5 retains the sensitivity while 
further improving overall performance. In  
this configuration two other relatively recent 
solid-state electronic devices are introduced : 
the backward diode and the vsracap diode. 
The backward diode serves a double purpose. 
First, it biases the tunnel diode oscillator into 
the region where frequency is insensitive to 
direct current variations caused by power sup- 
ply changes. Secondly, it functions as a tem- 
perature-stable voltage regulator. The capaci- 
tance of the varacap diode varies with th0 
input signal X, modulating the oscillator fre- 
quency. The input impedance of this circuit is 
raised to 100 megohms, compared with 1 meg- 
ohm for Model K-1. 
Multichannel implantable telemetry systems 
have been developed at  NASA, Ames Research 
Center (ref. 17), as well as at Case Institute 
of Technology (ref. 16). 
Power supply remains an outstanding prob- 
lem for implant biotelemetry, and NASA pro- 
grams have contributed toward its solution. 
Studies conducted at Ames examined the 
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FIQUBE 22.-TWo single-channel biotelemetry trans- 
mitter circuits developed at Case Institute of Tech- 
nology. 
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tradeoff between the short-life/long-range and 
long-life/short-range devices. Pulsed mode 
operation was one design approach. A pulsed 
bias allows the frequency-modulated transmit- 
ter to oscillate only when a subcarrier pulse is 
available for transmission, thereby reducing 
the power demand by the duty cycle of the 
subcarrier pulse. This revision was introduced 
in one of the Ames miniature biopotential te- 
lemetry systems. The pulsed mode operation 
increased battery life from 5 days to 4 weeks, 
and decreased the range from 100 to 10 feet, 
while leaving performance characteristics 
unaffected. Other ways of powering the im- 
planted telemetry unit are under development. 
These include piezoelectric devices, the trans- 
mission of power through the skin by induc- 
tion, and the use of body potential in various 
forms to supply the electronic device (ref. 18). 
ADDITIONAL CONTRIBUTIONS 
Three other signal conditioners are described 
briefly below. 
(1) Phonovibrocardiogram. This unit was 
developed by Ling-Temco-Vought for in-flight 
recording of heart sounds (ref. 19). It features 
a broad frequency response, with much of its 
conditioning circuitry integral with the micro- 
phone sensor. It has already been applied to 
clinical research. 
(2) Impedance pneumograph. A signal 
conditioner developed primarily for monitor- 
ing respiratory waveform during Gemini and 
Apollo flights. The circuit provides a wide 
acceptance range for input impedance changes 
without readjustment of parameters. It in- 
cludes a unique peak detector section and other 
novel circuit approaches imposed by small 
package size (refs. 1 and 20). The general 
concept of this instrument is discussed further 
in chapter 7. 
(3) Vectorcardiograph. Developed for the 
Apollo program, this combination of units 
permits in-flight recording of the vectorcar- 
diograph by the Frank lead system. A Frank 
lead module accepts inputs from seven active 
electrodes and maintains signal phase and 
common mode rejection ratio adjustments, 
, 
while providing an input/output impedance of 
1000000 ohms (exceptionally high for this 
measurement). Three standard Apollo ECG 
spaceflight signal conditioners complete the 
system. 
APPLICATION EVALUATION 
Many of the NASA-originated and NASA- 
sponsored developments in signal conditioners 
are readily adaptable to other biological re- 
search areas. KO and Slater (ref. 15) have 
stated : 
For future studies, researchers are calling for minia- 
turized electronic devices that can work inside the 
body ; the demand is for smaller and smaller units that 
can gather more and more information. . . . They must 
be light, . . . they must have long life, impose a mini- 
mum restriction on the subject's movements, and 
create as little reaction as possibIe in the body's bio- 
logical defenses against foreign matter. . . . Some of 
these problems are obvious to anybody who thinks 
about them ; others require close cooperation between 
engineers and life scientists. 
The biotelemetry devices being developed 
under NASA auspices are direct attempts to 
meet these stated needs and are certain to find 
application in future human and animal re- 
search work.4 I n  addition, NASA-sponsored 
programs are helping to establish the ground 
rules of engineering/life sciences cooperation 
in laboratory research and, perhaps more im- 
portant, in operational projects such as orbit- 
ing laboratories. 
From an engineering systems standpoint, 
however, the signal conditioners that best 
characterize NASA's contribution are the 
small, rugged units used in spaceflight itself, 
such as the ECG and EEG amplifiers dis- 
cussed above. I n  the main, these perform rel- 
atively simple functions. Their forte is high 
performance under adverse environmental 
conditions. They are very expensive compared 
'The clinical future of NASA biotelemetry was 
treated in the recent NASA Technology Utilization Re- 
port on space telemetry prepared by Hamilton Stand- 
ard Division of United Aircraft Corporation (ref. 4) .  
A NASA Technology Survey of blood pressure meas- 
urement (ref. 2) was published too early to include 
the Gemini unit discussed in this chapter. 
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to commercial units used for the same measure- 
ments. Alithough one might reasonably ques- 
tion their potential for nonaerospace applica- 
tion, it appears that these units, specialized as 
they seem, may well have significant in- 
ffuence on biomedical equipment and the bio- 
instrumentation system designer because space- 
flight specifications are elevating clinical per- 
formance standards. Table 5 illustrates this 
point by comparing the major performance 
specifications of ECG signal conditioners for : 
(1) typical commercial units available before 
major spaceflight activity ; (2) the Apollo 
unit, most recent of the NASA development 
line; (3) commercial standards recently recom- 
mended by the Subcommittee on Instrumenta- 
tion, Committee on Electrocardiography, 
American Heart Association (AHA) , ref. 21 ; 
and (4) a commercial unit currently available. 
In  such critical aspects as input impedance, 
common mode rejection, noise, and environ- 
mental operating range, the 1967 commercial 
ECG amplifier surpasses the AHA recom- 
mendation. The commercial model derived 
much of its circuit characteristics from the 
NASA Gemini and Apollo signal coqditioners. 
At present, this amplifier represents outstand- 
ing medical instrumentation ; but undoubtedly, 
other manufacturers will soon match it. Direct 
NASA influence at one source, then, will result 
in a general improvement of available instru- 
mentation, and most likely, an upward revi- 
sion of subsequent AHA recommendations. 
The same theme recurs throughout this report. 
Occasionally, specific NASA developments 
can’be applied “as is” to similar, or even novel, 
nonaerospace work. But more frequently, the 
main effect of the NASA effort is to set in 
motion technological advances over a broad 
front. 
TABLE 5.--XignaZ Conditioner Perf o m a n c e  
1965 1967 
Pre-1960 NASA AHA 1967 
Operating parameter commercial Apollo (ref. 21) commercial 
Frequency response 
Direct writing (Hz) 0.5 to 100 0.2 to 100 0.05 to 100 0.2 to 100 
Other recording (He) 0.05 to 2500 
Input impedance to 
ground (megohm) 
Common mode 
rejection ratio (db) 
Noise referred to 
input (RMS p V )  
0.5 44 0.5 10 
60 over 100 60 over 100 
10 2 10 2 
Environmental 
Temperature (“C)  ---- -20 to 70 10 to 50 0 to 55 
Pressure (psi) ---- 14.7 to 1.0 14.7 to 10 14.7 to 7 
Relative humidity (1%) -___ oto100 5 to95  0 to 100 
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CHAPTER 5 
Spaceflight Medical Monitoring 
NASA is engaged in a far-reaching effort to 
accumulate biomedical information regarding 
man’s ability to function in space. During 
manned flight, immediate biomedical data 
from the astronauts are combined with pre- 
viously gathered information by a medical 
monitoring team operating at Manned Space- 
craft Center in Houston. While the flight is 
in progress, the team must continually ascer- 
tain the immediate medical state of the astro- 
nauts; and, on the basis of incoming and 
historical data, determine their ability to con- 
tinue the flight and reenter the earth’s atmos- 
phere safely. After the mission ends, the team 
must use the newly acquired data in planning 
subsequent flights. 
This chapter describes the techniques 
adapted by NASA in the Gemini and Apollo 
programs to bring the required biomedical 
information to the medical monitoring team. 
NASA has termed its functional combination 
of techniques a “bioenvironmental information 
system” (BIS) . As was pointed out in chapter 
2, biomedical information requirements have 
changed during the course of the space pro- 
gram as missions have lengthened and mission 
objectives have become more varied. NASA’s, 
bioenvironmental information system has nec- 
essarily changed along with the space missions. 
I n  particular, the transition from the Gemini 
program to the operationally more complex 
Apollo program has resulted in extensive re- 
vision of monitoring equipment and monitor- 
ing philosophy. Some of the design rationale 
underlying the transition is presented to illus- 
trate NASA’s approach to this important 
bioinstrumentation problem. 
SPACEFLIGHT DATA TRANSMISSION 
For the Gemini flights, medical decisions 
emanated from the medical monitoring team 
at the Houston Mission Control Center 
(MCC). These decisions were based on telem- 
etered data originating from the spacecraft 
bioinstrumentation system and reaching Hous- 
ton via several telemetry links (ref. 1). Figure 
23 shows the general flow of data from the 
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FIGWE 23.-Gemini/Apollo data transmission system. 
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FIGURE 24.-Tracking stations-Gemini/Apollo 
Manned Spaceflight Network. 
spacecraft to the medical monitor’s console 
at the MCC. Before launch, data came directly 
from the launch complex at  Cape Kennedy. 
After launch, the Cape Kennedy complex 
became part of the worldwide Manned Space 
Flight Network (MSFN) . The MSFFN consists 
of a number of tracking stations geographi- 
cally distributed, as shown in figure 24, to 
track and maintain radio contact with the 
spacecraft throughout its flight. The number 
of stations actually able to acquire the space- 
craft, however, varies with the specific orbit ; 
and the time that the station is in contact 
with the capsule also varies. 
Several of the ground tracking stations- 
Hawaii, Texas, Cape Kennedy, Grand Baha- 
ma, Grand Turk, and Antigua-are connected 
with the MCC through high-speed data lines. 
These stations relay the biomedical telemetry 
virtually unchanged to Houston. The other 
tracking stations have only low-speed teletype 
and voice links to the MCC. At some of these 
stations, particularly on board ship, the bio- 
medical data are reduced on site, and summary 
messages are sent on to Houston where they 
are intercepted by the medical monitor for dis- 
play and evaluation. The incoming data are 
taperecorded at the remote sites, however, so 
that if the teletyped summary indicates an 
anomalous situation, the original data can be 
scanned for the source of trouble. 
GEMINI MEDICAL MONITORING 
Gemini medical monitoring depended heavi- 
ly upon examination of the raw safety data as 
they were received from the orbiting space- 
craft (see table 3). Each time the spacecraft 
was acquired by a ground station, two ECG 
signals and the respiration waveform signal 
for both astronauts were routed to the central 
medical monitor’s station for recording and 
analysis. At specified intervals during the day, 
the MCC monitor also received blood pressure 
signals, consisting of Korotkow sounds super- 
imposed on an arm cuff pressure decay curve. 
These signals were recorded on a direct-writing 
recorder as they were received; figure 25 pre- 
sents a typical portion of Gemini biomedical 
data. Oral temperature readings taken in flight 
were transmitted periodically by voice com- 
munication. 
Although the Gemini medical monitors had 
available cardiotachometers and respiration 
tachometers for meter displays of rate infor- 
mation from the ECG and impedance pneumo- 
graph signals, they preferred to derive these 
values by hand measurement of the strip chart 
records, using plastic scales or reference marks 
on the recorder platen. I n  some ways, this pro- 
vided greater flexibility of observation. For 
example, during a portion of the Gemini VI1 
flight, astronaut Borman’s respiration channel 
malfunctioned and respiration rate was deter- 
mined by the heart axis deviation observable 
on the sternal ECG. On the whole, however, 
the procedure reflected a lack of confidence in 
the tachometry circuits and associated analog 
meters. 
The rates recorded by measurement at  
Houston were logged by the medical monitor 
at his console and transmitted by telephone to 
the flight surgeon in the main Mission Control 
Room. The same type of heart rate and res- 
piration rate measurements were made by 
medical monitors at the remote tracking sites. 
I n  their teletyped messages to the MCC, they 
reported : 
(1) Heart rate (mean, minimum. and modal 
value) 
(2) Respiration rate 
(3) Medical comments (such as ECG nor- 
(4) Other related information (cabin COz 
mal) 
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FIGUBE 25.-SampIe of Gemini biomedical data. 
FIGWBE 26.-Gemini remote site aeromedical monitor- 
ing console. 
reading, status of the biomedical tape recorder, 
malfunctioning channels, etc.) 
The teletyped summary messages were posted 
as they arrived at Houston and arranged so 
that the last few messages could be seen on the 
MCC closed circuit TV system. Figure 26 illus- 
trates the Aeromedical Monitor's Console in- 
stalled at the remote stati0ns.l The console 
provided for analog waveform display 
through oscilloscope and strip chart recorder 
and for a meter display of heart rate infor- 
mation. 
Along with the abbreviated rate summaries, 
a more complete analysis of the ECG wave- 
form and blood pressure data obtained on a 
telemetry acquisition was performed by the 
medical monitoring team at MCC. Figure 27 
presents the NASA log sheet for this infor- 
mation, which was also obtained by hand meas: 
urement of the strip chart recordings. Twice 
a day, the following data were also summa- 
rized for each crew member: 
(1) Oral temperature 
(2) Heart rate 
* These consoles were developed for the Gemini pro- 
gram by Bendix Pacific Division, North Hollywood, 
Calif. 
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MEASURE ME NT PRE-EX. 
(3) Respiration rate 
(4) Blood pressure-pre-exercise 
(5) Blood pressure-post-exercise 
(6) Highest heart rate for that period (12 
(7) Food, water, and sleep report 
(8) Urine and feces elimination 
hours) 
Heart rate, respiration rate, and blood pres- 
sure were plotted against Gemini Elapsed 
Time (GET), and displayed to the flight 
POST-EX. 
surgeon on demand through the closed circuit 
TV system. 
I n  addition, the medical monitoring team 
had available several data summary charts 
generated by the main computing equipment, 
which could be viewed on specific TV channels. 
These charts consisted of: 
(1) Gemini (GEM) physiological temper- 
atures. A plot of command pilot suit tempera- 
ture, pilot suit temperature, and cabin air tem- 
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MEASUREMENT I PRE-EX. I POST-EX. 
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PP X HR I I 
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FIGWE 27.-Gemini electrocardiographic log format. 
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perature versus GET, generally for several 
hours. 
(2) G E M  physkZogiCal meters. A chart 
presenting various temperatures and pressures 
relating to the environment and suit at a 
specific time, as well as oral temperature 
(when available). 
(3) GEM physiological summary tab. A 
chart summarizing avaiZabZe physiological data 
and certain cabin environmental data for the 
last three data acquisitions of the spacecraft. 
(4) GEM physioZogicaZ summary history 
recaZZ. Similar to Chart 111, except that flight 
history 12 hours old was presented. 
( 5 )  G E M  physiological summary history. 
Similar to Chart I11 ; six previous passes plot- 
ted. 
Although these charts theoretically pro- 
vided for physiological data summary, no 
physiological information appeared on them, 
because no provision was made in the main 
computer system for handling these data. The 
main use of the charts to the medical monitor, 
then, was in roughly comparing the manually 
derived data with posted environmental varia- 
tions in the spacecraft. 
Several computer processing routines were 
applied to short samples of the flight safety 
data on an experimental basis during the later 
Gemini missions. A computer program was 
written to derive the following heart rate 
information from the raw ECG signals, using 
analog tapes generated at  Mission Control as 
input: (1) mean, (2) standard deviation, (3) 
variance, (4) maximum, and ( 5 )  minimum. 
A second experimental arrangement utilized 
computer analysis of ECG waveforms to pro- 
duce a clinical diagnosis during the space 
missions. 
For postflight data analysis, analog tape in 
standard format was produced by a series of 
conversions of the specialized tape from the 
in-flight recorder. Respiration rate and heart 
rate information was generated from the final 
tape by playing it back through a cardio- 
tachometer and respiration tachometer to pro- 
duce a tape that had two zero crossings per 
beat or breath. This tape (including a time 
code) was then fed to an analog-to-digital 
converter to derive a digital tape for use with 
a computer. The computer was programmed to 
derive heart rate and respiration rate recorded 
and to develop plots of heart rate and respira- 
tion rate versus time. 
APOLLO MEDICAL MONITORING 
I n  preparation for the Apollo program, 
NASA has markedly updated the BIS, partic- 
uIarly the biomedical data displays, and the 
medical monitors’ control over the incoming 
data (refs. 3, 4, and 5). Figure 28 presents 
the data flow paths in the new system installed 
at  MCC.2 
The biomedical preprocessors are designed 
to handle ECG and impedance pneumograph 
(ZPN) signals from several astronauts simul- 
taneously on single or dual missions (i.e., one 
to three astronauts simultaneously from each 
of two spacecraft). There are two cardiota- 
chometers, two respiratory rate units, and an 
ECG waveform analyzer. A 30-second FM 
tape loop recorder receives the same signals as 
the biomedical preprocessors and provides a 
30-second delay of selected real time signals. 
The delayed signals are displayed on strip 
chart recorders upon request. 
Each of the cardiotachometer and respira- 
tory rate preprocessors digitizes a selected 
ECG or ZPN analog signal. The outputs pro- 
vide digital signals representing instantaneous 
and average rakes, computed over 6, 10,15, or 
30 seconds. I n  addition, each tachometer pre- 
processor provides an analog heart rate and 
respiration rate signal for display on the strip 
chart recorder. The input to the ECG wave- 
form analyzer is a selected ECG signal from 
the patch board ; the output is a digital repre- 
sentation of the ECG complex. 
Digital outputs of the preprocessors enter a 
Univac 494 computer which prepares the data 
to be fed to the larger IBM/360 (part of the 
Real Time Computer Complex). The Univac 
494 tags the incoming *raw data with GMT 
words, astronaut identification, and activity 
This system and the subsequently described Aero- 
medical Console were developed and installed by 
Philco Gorp., Houston. 
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F I Q ~  28.-Bioenvironmental data system, NASA Mission Contrd Center, Houston. 
mode tags supplied from the aeromedical con- 
sole through the interfacing CIM computer. 
The IBM/360 processes the real-time rate data 
as they are received from the Univac 494. It 
checks the data for abnormalities by compar- 
ing the actual rate levels with acceptance 
ranges stored before or during the mission. 
Should an abnormality occur, the IBM/360 
sets an alarm on the aeromedical console 
through the digital display driver, which 
simultaneously assigns a digitized event code 
to the abnormality. 
The IBM/360 also manipulates the input 
data and generates real-time data summaries 
of heart and respiration rates. These sum- 
maries are displayed on a scope face at  the 
console through the video transmission matrix, 
which switches to any one of two sets of data 
on a dual mission. The summaries present the 
mean, maximum, minimum, standard devia- 
tion, and variance of heart and respiration 
rates. This information is also stored in the 
computer, to be available “on-call” for mid- 
and postpass summaries and for subsequent 
automatic retrieval. 
The aeromedical console pictured in figure 
29 is the operations center of medical monitor- 
ing activity. One unit is in the Staff Support 
FIGURE 29.-Aeromedical console, NASA Mission Con- 
trol Center, Houston. 
Room (SSR) ; its information display capa- 
bilities are shown schematically in figure 30. 
These displays provide the monitoring sur- 
geons with : 
(1) TV and cathode ray oscilloscope 
(CRO) displays : 
a. Digital readout of continuously up- 
dated instantaneous heart rate, average heart 
rate, and average respiration rate 
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FIGWE 30.-Display modules of the MCC aeromedical 
console. 
b. Digital display of environmental para- 
meters 
c. ECG waveform overlay (real time and 
playback) 
d. Data summaries for specific past inter- 
vals, as well as playback display and raw data 
shown for the previous 6 data hours. This in- 
formation is obtained on demand from tape 
memory. 
(2) Strip chart recordings: 
a. Incoming signals, raw or preprocessed 
b. Abnormal signals immediately as limit 
c. Incoming signals from 30 seconds 
rates, at monitor’s request. 
crossings are recognized by computer 
previous 
(3) Printed postpass summaries : 
a. Pass identification (site, date, time, 
b. Identification of crew member samples 
e. Astronaut activity summary 
d. Heart rate summary (mean, standard 
length) 
deviation variance, maximum, minimum) 
(4) Teletype hardcopy : 
Computer-printed summaries, reviewed by 
the medical staff before transmittal to the 
remote monitoring sites 
( 5 )  Alarms: 
a. Single alarm indicator illuminated 
upon limit crossing 
b. Multiple alarm indicator signaling 
second alarm occurring before reset 
A similar console in the Mission Qperations 
Control Room (MOCR) includes all SSR dis- 
plays except the strip chart recorder. By 
means of the console controls, the medical 
monitor selects available information for dis- 
play, specifies particular operations on stored 
data, and reenters observations into computer 
memory. Table 6 summarizes the major con- 
trols and their function, illustrating the oper- 
ating potential of the aeromedical console. 
BIOENVIRONMENTAL INFORMATION SYSTEM: 
DESIGN EVOLUTION 
The Bioenvironmental Information System 
(BIS) employed during the Mercury and 
Gemini missions reflected a “clinical” monitor- 
ing strategy-in essence, a qualitative ap- 
proach based on medical experience and rule- 
of-thumb analysis. Biomedical data were pre- 
sented to the medical monitors largely in raw 
analog form. The medical monitors were 
engaged primarily in visual inspection of an- 
alog displays (cardioscopes, strip charts, and 
meters) and manual reduction of incoming 
data. The medical monitor’s assignment in- 
cluded many routine mechanical operations. 
Lack of automated data recall made it difficult 
to compare real-time flight data from previous 
missions and with ground-based data. Most of 
the complicated data reduction and data anal- 
ysis was carried out postflight, using informa- 
tion from the strip chart records and the tape 
recovered from the onboard flight recorder. 
Thus, for the most part, the medical decision 
process was carried out on an “open loop” 
basis, without significant feedback. Successful 
monitoring depended heavily on the profes- 
sional competence and the continuous presence 
of the medical staff. 
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TABLE 6.-Major Control Operations of MCC Apollo Aeromedical Console 
Console unit Control Function 
TV monitor Mode Selects (1) RTCC (any data from the IBM/360 
Cornput&), or (2) biomed real-time or  summary 
data. 
Cardioscope Mode Selects (1) normal display of real time or playback 
EGG waveform, or (2) overlay display of succes- 
sive complexes. 
Computer Mode Selects (1) playback of any raw data from previous 
6 hours, or ( 2 )  summary printout or display of 
data for selected time period. 
Computer printout of data summary teletyped to 
remote sites after approval by medical officer. 
Teletype 
Limits Establishes upper and lower limits on selected 
variables. 
Identification Astronaut One of three astronauts is manually identified by 
pushbutton. 
Astronaut activity is classified by pushbutton into 
(1) Normal, (2) Sleep, (3) EVA, (4) Exercise, 
( 5 )  Suited, (6) Unsuited. 
Activity 
EGG input Select One of four monitoring conditions is selected: (1) 
axillary, (2) sternal, (3) EVA, (4) lunar module. 
With the completion of the Gemini program, 
the focus of medical monitoring shifted from 
immediate safety to long-term operational and 
experimental aspects. It has become necessary 
to provide hhe medical monitoring team with 
information describing the crew's potential to 
survive and operate in space for an extended 
period of time, as well as with information 
concerning their immediate medical status. The 
updated BIS design reflects NASA's transi- 
tion from the clinical to the operational ap- 
proach. The new system is more automated; it 
offers a greater amount of descriptive informa- 
tion and better feedback capabilities for deci- 
sion making. 
Automation is introduced at  several stages 
in the new system. Incoming data are immedi- 
ably digitized by analog-to-digital conver- 
' 
sion units. The digitized data are buffered, 
processed, and manipulated by a high-speed 
computer. Consequently, descriptive parame- 
ters can be displayed in digital format; and a 
variety of computer-generated summaries and 
plots are made available to the medical staff. 
Data compression is accomplished on succes- 
sive levels : instantaneous displays, daily sum- 
maries, flight summaries (a collection of the 
daily summaries), and postflight analyses. 
Tabular summaries and plots of any combina- 
tion of dependent variables help the monitor- 
ing team recognize trends in physiological re- 
sponse. The system offers both automatic and 
manual data retrieval capability. Storage of 
physiological limits for various stress condi- 
tions in the computer permits the installation 
of automatic alarms. System efficiency is also 
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enhanced by display facilities that correlate 
biomedical and environmental parameters. In  
combination, these features increase feedback 
and at the same time remove a great deal of 
the routine workload so that the medical moni- 
toring team can devote more time to decision 
making. 
NASA planning personnel (refs. 6 and 7) 
expect BIS to continue to evolve. The current 
objective is to reduce and analyze as much raw 
data as possible in real and near-real time, and 
to close gradually the gaps between data ac- 
quisition, data interpretation, and research. As 
the capabilities for realtime analysis increase, 
the system will assume a more descriptive and 
inferential nature. The inferential characteris- 
tic will be added by ?:plying appropriate 
statistical tools. Realtime waveform analysis 
will further strengthen the descriptive func- 
tion, and mathematical models of physiological 
processes will supplement statistical analysis 
(ref. 8). The combination of the two will add 
a predictive capability to the system; and, as 
more basic space data are acquired, may lead 
eventually to some automation of the medical 
decision process. (In the updated BIS, auto- 
mation goes only as far as supplying informa- 
tion in an appropriate format to the medical 
monitors, the decision makers.) Finally, it is 
expected that the application of modern com- 
munication and information theory concepts to 
the biomedical signals will permit substantial- 
ly more onboard data compression, offsetting 
the limitations of downlink channel capacity 
(ref. 9). 
APPLICATION EVALUATION 
Comprehensive and continuous patient mon- 
itoring currently represents one of the most 
rapidly growing facets of clinical medicine. 
Although real-time monitoring is initiated for 
a variety of reasons, including research data 
acquisition and diagnosis, intensive patient 
care is perhaps the activity most amenable to 
the influence of NASA technical contributions. 
Within the last few years, many hospitals have 
initiated intensive care procedures as a means 
of preventing the deaths of their patients. 
These procedures generally share the follow- 
ing characteristics : 
(1) Assembly of all critically ill patients 
in an easily supervised, compact area, general- 
ly called the intensive care unit (ICU). The 
ICU may consist of the postanesthesia recov- 
ery room, the postoperative recovery room, the 
cardiac care unit, or some combination of these. 
(2) Round-the-clock individual care by 
nurses specially trained in handling emergen- 
cies and sometimes especially selected to handle 
responsibilities approaching those of the at- 
tending physician. 
(3) Use of some type of semiautomatic 
monitoring equipment attached to each patient 
to warn the nurse and other cognizant per- 
sonnel of serious changes in his condition. 
Generally, the monitoring equipment will 
inform the nurse of an emergency (for ex- 
ample, cardiac arrhythmia) and the nurse will 
call in physicians and nearby specialized ap- 
paratus, while starting emergency aid pro- 
cedures. Within a few seconds, a skilled team 
can be assembed to cope with the medical prob- 
lem. Recent efforts in the field of shock mon- 
itoring have made use of small and medium 
sized computers as elements in the linkage 
between patient and medical monitor (refs. 10 
and 11). 
The main purpose is to utilize fully the few 
minutes in which death can still be averted. 
Intensive care thus involves a unique symbiosis 
of men and machines; it consists of long peri- 
ods of passive monitoring interspersed with 
brief bursts of swift activity. There is no doubt 
that this technique can save lives. It is, how- 
ever, quite expensive and is demanding of 
personnel. 
When adaptat.ion of a desirable innovation 
is hampered by its cost and when much of that 
cost arises from skilled labor, technology may 
have something to offer toward a solution to 
that problem. The production of consumer 
goods exemplifies this point. Of course, the 
problems associated with intensive patient care 
are not the same as those of assembly lines, 
but if the skills of the nurses and physicians 
can be employed better by the judicious use of 
equipment and technique, many more lives 
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might be saved than are now, with li,ttle more 
expenditure. 
There are many reasons why space monitor- 
ing techniques would be beneficial to hospital 
applications, but perhaps the most outstand- 
ing is the application of space technology’s 
system philosophy from the start. As Meltzer, 
Pinneo, and Kitchell point out, “The concept 
of intensive coronary care as a system is funda- 
mental to the entire success of this program” 
(ref. 12). Although some hospitals have uti- 
lized systems concepts in planning (ref. 13), 
much of the instrumentation previously pro- 
duced for hospital monitoring has not reflected 
a systems design approach. Equipment design 
and installation have often been ad hoc, ne- 
glecting such factors as basic information 
requirements, unit interfacing, demands on op- 
erating personnel, and operating room or bed- 
side clutter. NASA spaceflight monitoring 
experience provides valuable examples of 
largescale system development. More impor- 
tant, perhaps, the evolution in NASA systems 
design, spurred by changing space monitoring 
needs, presents the designer of patient monitor- 
ing systems with some guidelines that may 
aid him. 
It is frequently nassary,  however, for the 
medical designer to modify some aspect of 
NASA system implementation, while main- 
taining the same basic principles. For example, 
at  the Manned Spacecraft Center, real-time 
biomedical data processing represents a sub- 
task of the large central computer. This is an 
excellent approach when such a facility with 
the requisite spare capacity is available. Hospi- 
tals may not yet have large computer installa- 
tions or the existing computer may be com- 
pletely occupied by other tasks. In  such cases, 
there are still ways to obtain the benefits of 
computer-aided monitoring by using the new 
class of small computers, discussed further at  
the end of chapter 6. Similar considerations 
apply to the NASA techniques of data acquisi- 
tion and special display generation. 
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CHAPTER 6 
Advances in Biomedical Data Processing and Analysis 
This chapter describes several advanced 
techniques developed under NASA sponsor- 
ship for the processing and analysis of bio- 
medical data. The objective has been to nar- 
row the gap between data processing and data 
analysis, which from the technical point of 
view are inherently related, inasmuch as the 
means by which biomedical data are analyzed 
depends to a large extent on the processing 
scheme. From an operational standpoint, 
merging the two procedures permits faster 
data interpretation, which is valuable equally 
in space and at crihical ground installations. 
The contributions presented here illustrate 
the merger process in different ways. The time- 
line approach links descriptive statistics to 
slices of raw data. “Yes/no” reduction pro- 
vides a simple descriptive framework for 
continuous data. Both the time-line approach 
and the “yes/no” method yield processed data 
ready for immediate computer input and fur- 
ther analysis. The EEG contour map serves 
as an effective data compression tool and, at  
the same time, offers an immediate means of 
analysis and interpretation by visual inspec- 
tion. This is also true of such mathematical 
processing techniques as waveform averaging 
and signal autocorrelation. 
Sophisticated hardware and mathematical 
techniques lie at the core of most of these data 
processing methods. NASA has learned that 
application of these tools requires careful 
judgment at each stage of the processing chain. 
For example, extremely coarse analog-to- 
digital conversion of prime data may result in 
losses of information which cannot be restored 
by even the most sophisticated computer tech- 
niques. On the other hand, using higher sam- 
pling rates than necessary increases the cost 
and the time needed for analog data process- 
ing. Again, “clean” biomedical signals can be 
obtained by operations such as filtering and av- 
eraging. These operations are effective in re- 
ducing noise, improving the signal-to-noise 
power ratio and delivering a “smoother” wave- 
form. However, in these processes, relevant 
information may also be averaged, filtered, or 
integrated out. Along these lines, Jasper has 
stated that one of the problems in the use of 
compu-ters in the work on the brain is the loss 
of information in averaging data (ref. 1). 
I n  planning data processing, then, one must 
take full account of the nature of the primary 
data. Mathematical methods of analysis must 
be carefully evaluated and adopted in accord- 
ance with both the signal structure and the 
overall medical objectives. The NASA ex- 
amples discussed here are results of such ex- 
aminations. Satisf actory results were obtained 
only after optimal values were found for the 
various parameters involved, such as sampling 
rate, number of samples to be averaged, period 
of integration, bandwidth, and others. Equiv- 
alent examinations would be needed in ter- 
restrial medicine. 
TIME LINE MEDICAL DATA 
I n  the space program, medical data are ac- 
quired almost continuously during spaceflight 
and ground simulation. These data have to be 
prepared for effective in-flight and postflight 
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scrutiny and analysis. During a mission, the 
main objective is to have the data in proper 
form for comparison with data from other 
missions or other phases of the same mission. 
The postflight objective is to have the data 
available in a computer-compatible form for 
further research and analysis. Both objectives 
require the data to be arranged in a standard, 
interchangeable format. A method termed the 
“Time Line Approach to Data Tabulation and 
Compression’’ was developed at  NASA to sat- 
isfy these requirements (ref. 2). 
The time line method is a hierarchical struc- 
ture. Its basic element is the single data sheet 
that contains all relevant biomedical informa- 
tion for a given time interval of a space mission 
or a space simulation run. During stressful 
periods, such as exit and reentry, when var- 
iables change rapidly, the time interval chosen 
is shorter than under less stressful conditions. 
The next level of the hierarchy is a matrix of 
single data sheets ; the last level is a matrix in 
which athe entries are sets of data sheets. The 
medical data from the Mercury and Gemini 
flights were prepared in time line format. 
PILOJECT WRCURY 
MERCURY 4TLAS N O .  
TIME-LINE DATA 
Figures 31, 32, and 33 represent samples from 
that data accumulation. 
Figure 31 illustrates a 10-second interval 
data sheet and the analog record from which 
the tabular data were derived. The tabulated 
data contain information concerning the astro- 
naut’s physiological state and performance, as 
well as the spacecraft environment. I n  addi- 
tion to the digitized raw data, descriptive sta- 
tistical parameters such as mean, standard de- 
viation (sigma), variance, and standard scores, 
are included. The data sheet beading specifies 
the mission (Mercury Atlas MA-9) and the 
mission elasped time to which data on the 
sheet pertain (20 to 30 seconds after li&-off). 
The astronaut’s activity during the 10-second 
interval is recorded under the heading of 
“communications.” During this particular in- 
terval, ,the astronaut started the backup clock. 
Activities are digitally coded in terms of crit- 
icalness, difficulty, duty, and procedure for 
computer storage. The individual data sheets 
were -transferred to magnetic tape, and stored 
for subsequent analysis. 
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PIMIBE 31.--Time-line data sheet for a 10-second interval of a Mercury flight. 
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X = ONE DATA SHEET 
FIGURE 32.-Summary of available data sheets for 
sequential time intervals, Mercury and Gemini flights. 
Figure 32 presents a fine summary of avail- 
ab16 data sheets for several space missions. 
Each row of this matrix contains the medical 
data over a period from launch minus 60 min- 
utes to launch minus 15 minutes for a single 
mission. Each matrix column contains data of 
like time periods for different missions. The 
consecutive data sheets available in a row yield 
the continuous data for a particular mission 
phase, while the vertical sheets comprise the 
medical information from similar epochs of 
different missions. 
Figure 33 illustrates a coarse summary of a 
similar group of missions. It represents a 
breakdown of the spaceflight mission by spe- 
cific periods during which data were collected 
and organized in time line format. It covers 
the Mercury program, indicating what data 
tabs (tabular summaries) are available per 
flight, what periods can be compared among 
flights, and, for the comparison periods, how 
fine are the tabulated data samples. The mat- 
rices are ideal analytic tools for the medical 
monitors. 
YEWNO DATA REDUCTION 
Thousands of feet of strip chart and mag- 
netic tape records are collected during pro- 
longed aerospace missions. Analyzing ,the data 
manually is time consuming and requires 
highly qualified personnel for coding and in- 
terpretation. “Yes/no” data reduction is one 
of several methods developed to cope with 
large amounts of biomedical information. 
Described by Sem-Yacobson et al., it has been 
applied it0 flight data acquired at the NASA 
Flight Research Center (ref. 3). 
The technique is based on reduction criteria 
that determine what information in the pri- 
mary signal should be retained after the re- 
duction process. The criteria themselves am de- 
termined by the investigator’s objectives. Crite- 
ria may relate to signal amplitude, period, 
slope, or any combination of these parameters. 
The method is termed “yes/no” because it 
yields only binary information concerning the 
signal parameters ; i.e., the resultant output 
contains no numerical values but indicates only 
if the limits of each criterion are exceeded 
(“yes”) or not (“no”) as a function of time. 
The amount of signal information retained 
after reduction depends on the number of cri- 
teria chosen. 
Figure 34 is an example of twofold “yes/no” 
reduction-amplitude and duration-applied 
to a representative waveform. The left col- 
umn of figure 34 shows the sequence of opera- 
tions performed on the primary signal to 
detect whether the signal exceeds $the duration 
threshold, while the right column describes the 
equivalent for the amplitude ,threshold. The 
primary signal in A is rectified to produce the 
trace in B. The trace in 17 is a dc voltage that 
starts when the primary signal goes from a 
negative to a positive value and is reset to 
zero when the primary signal goes from a 
positive to a negative value. The pulses in D 
are triggered by a one-shot generator when 
the primary signal changes from a negative to 
a positive value. 
constant rate, 
starting from zero at the instant specified by 
the first pulse in D,  and is reset to zero at the 
instant marked by the second pulse in D. This 
voltage translates the time duration of the 
period of the primary signal into a voltage 
amplitude. The period threshold of the crite- 
ria, marked by the dotted line in E, is com- 
pared with &his voltage. I f  Athe lines intersect, 
The voltage in E increases af. 
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FIGUBE 34.-Signal reduction waveforms resulting 
from the “Yes/No” analysis technique. 
the period of the primary signal exceeds the 
specified threshold. This is registered by the dc 
voltage in G. The voltage in G begins at the 
instant at  which the solid line in E exceeds 
the dotted line. This voltage is transferred to 
I ,  where it remains until information is ob- 
tained regarding the next period of the pri- 
mary signal. 
The primary signal is routed through a simi- 
lar sequence of operations for the amplitude 
criterion, as illustrated in the right-hand col- 
umn of figure 34. I f  the voltage in B exceeds 
the set threshold, the overflow is indicated by 
the dc trace in P. The voltage in P is trans- 
ferred to H ,  where it remains during the proc- 
essing operation of the next period of the pri- 
mary signal. The information from I and H 
is fed into a mulatichannel perforator which 
codes the information on punched tape. The 
tape, then, represents a continuous record of 
“yes/no” decisions for the parameters and 
criteria selected in one or several biomedical 
signals. It can be used to detect changes of 
physiological state which appear as changes 
in the pattern of threshold crossings. 
SIGNAL AVERAGING 
Signal averaging is a mathematically simple 
technique that has proved of great benefit to 
biomedical data analysis. NASA-sponsored 
studies have employed several variations of 
this approach. Basically, averaging involves 
computation of the continuous arithmetic 
mean over a number of ensembles o 
degraded signal. The ensembles 
waveform samples, and the result of the sum- 
mation is a characteristic or average wave- 
form. 
All biomedical measurement signals are con- 
taminated somewhat by distortions caused by 
artifacts and noise. I n  extreme cases, a peri- 
odic signal may be virtually buried in random 
noise. Averaging techniques will cancel a good 
portion of the random noise, while accentuat- 
ing the harmonic portions of the signal, so 
that the signal-to-noise r&io is markedly in- 
creased. Theoretically, the ratio is improved 
by the square root of the number of samples 
included in the sum. (Averaging 16 samples 
improves the signal-to-noise ratio by a factor 
of four.) Actually, this improvement may not 
be fully realized, since the noise may not be 
entirely random, among other factors. To en- 
hance the signal while canceling noise, some 
unique shape in the waveform is used as a 
reference for the summation. I n  the case of 
the ECG complex, the R wave is generally 
used as an anchor point. Other points must be 
found for other periodic biomedical signals. 
I n  the case of evoked responses, the repetitive 
stimulus is often used as a trigger for sum- 
ming the subsequent responses. 
The operational speed of computers has 
permitted signal averaging to be done on-line. 
For example, on-line averaging was success- 
fully employed in recording cardiac vibration 
during exercise in a study reported by C. M. 
Agress et al. (ref. 4). Previously, high-level 
noise (associated with subject motion) re- 
stricted the recording of chest-wall vibration 
to static conditions. I n  the study undertaken 
by Agress, motion antifacts mere essentially re- 
moved, so that transitions from rest to exercise, 
and from exercise to recovery, could be easily 
identiiied. Before the averaging technique was 
applied, records were rendered useless by mo- 
tion artifact. 
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HEART RATE BY AUTOCORRELATION 
PROCESSING 
The autocorrelation function can be con- 
sidered a measure of periodicity. For some 
time, it has been used to observe hidden perio- 
odicities in EEG signals. Recent development 
work originated and coordinated by NASA's 
Flight Research Center (FRC) at  Edwards 
Air Force Base, Calif., has demonstrated that 
this technique is equally valuable in extracting 
heart rate information from the severely de- 
graded ECG signals common in field records 
(ref. 5 ) .  
Mathematically, the autocorrelation func- 
tion of a stationary signal f ( t )  is defined by 
ei#ther of two expressions : 
=lim 1/27' f ( t + ~ )  f ( t )  dt;t 
T-W ST-, 
T- W L 
or 
e ( ~ )  =lim 1/2T f ( t - r )  f ( t )  d t  
where : 
T = specific time interval, and 
0 ( r )  =the autocorrelation of f ( t )  at T 
The definition implies that autocorrelation 
is a process of shifting the signal with respect 
to itself, multiplying, and averaging. The auto- 
correlation function at T is calculated by shift- 
ing f( t )  ahead by 7 seconds and averaging the 
product of the original and shifted functions, 
The same result is obtained if the function is 
shifted backwards by r seconds. Consequently, 
the average product is independent of the di- 
rection of the shift. The autocorrel 
T=O (no shift) is equd to the aver 
of the time function, i.e., the average value of 
the function multiplied by itself. It represents 
the maximum value of the autocorrelation 
function, since any shift necessarily reduces 
the value of the products f ( t )  - f ( t + ~ ) .  I n  
practical applications ;the period over which 
the autocorrelation function is calculated is 
obviously finite, rather than infinite as stated 
in its definition. (This limitation decreases the 
reliability of the derived values.) 
If a signal contains periodic components, the 
autocorrelation function contains components 
of the same periods. This can be seen, since a 
periodic wave shifted by one period is in- 
distinguishable from the unshifted wave. On 
the other hand, the autocorrelation component 
caused by random noise decays exponentially 
as the time shift increases. I f  there is a dc 
component in the signal, there will be a dc 
component in the autocorrelation which will be 
independent of the time shift. Consequentlx, 
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FIGUBE 35.-NoigY ECG recording from an X-15 test flight. 
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FIGURE 36.-Normalized autocorrelation of noisy EGG recording. 
the autocorrelation function is a powerful tool 
with which to determine the fundamental na- 
ture of a recorded biomedical signal, particu- 
larly when the signal contains periodic ele- 
ments masked by random noise. 
Degraded ECG signals are of this ‘type, 
since the EGG complex has a nearly periodic 
feature. Figure 35 shows a 6-second segment 
of ECG recording from an X-15 rocket air- 
craft flight test at NASA/FRC. The signal- 
to-noise ratio is less than 1.0, the characteristic 
ECG complex is effectively masked, and it 
would be virtually impossible to extract heart 
rate data by standard automatic means. Figure 
36 is the autocorrelation function for this 
record segment. The innate periodicity is 
easily seen, and it is simple to derive average 
heart rate for this record interval from the 
clearly defined spikes. (Heart rate is the 
reciprocal of the approximately 0.44-second 
interval between spikes.) Although the auto- 
correlation function exhibits some similarity 
to the R wave of the ECG itself, it is not the 
same. All portions of the ECG signal(P, &, 
R, S, and T waves) contribute to the ampli- 
tude and shape of the spike in the autocorrela- 
tion function. To obtain meaningful results, 
the autocorrelation parameters must be chosen 
with regard to the signal under analysis. De- 
tailed studies were undertaken under the direc- 
tion of NASA/FRC to determine the best 
parameters (sampling rate, integration time, 
etc.) for various biomedical signals with a 
variety of prefiltering arrangements. Partial 
results are available in reference 5 ; subsequent 
NASA reports will contain additional details 
of the ECG processing procedure. 
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DIGITAL FILTERING 
When signal and noise lie in different fre- 
quency bands, a filter can be constructed that 
eliminates more of the noise than the signal, 
enchancing the signal-to-noise ratio. Properly 
programmed, a computer can be made to act 
as a digital equivalent of a standard analog 
filter circuit. The digital filter is superior to 
the analog because it offers complete control of 
phase shift, provides sharp cutoff, and has 
bandpass characteristics which can be precise- 
ly specified. 
Digital filtering can be visualized as an 
operation that applies preset weighting factors 
to the frequency components of the incoming 
signal. The usual design technique is to vary 
the filter parameters until a best fit, in the 
least squares sense, is obtained between the 
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actual and the theoretical filter response to an 
impulse input. Digital filtering has been ap- 
plied to a variety of biomedical data. 
Figures 37 and 38 are samples of ECG 
records obtained during the X-15 test flight 
as processed by two digital filte 
in a study sponsored by the 
Research Center (ref. 5). The lower plot in 
figure 37 shows the raw ECG signal. The up- 
per plot shows the same signal after it was 
filtered by a lowpass filter with an 18-Hz cut- 
off frequency. As can be seen, the noise has 
been greatly reduced by the filtering operation.. 
Figure 38 shows the ECG signal with a band- 
pass filter employed. The bandpass was 0.5 
to 20 Hz. This filter however, removed the 
dc component as well as a good part of the 
respiration effect. The latter is particularly 
908. 908.5 909. 909.5  910. 910.5 911. 911.5 912. 912.5 913. 913.5 914. 
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FIGUBE 37.-Effect of low-pass (18-Hz) digital filtering on a noisy EGG signal. 
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important when the €2 wave is used as a trig- 
ger in a cardiotachometer or as an identifica- 
tion mark in computer ECG analysis. 
POWER SPECTRAL DENSITY ANALYSIS 
The power spectral density of a signal gives 
the power density (watts/Hz) as a function 
of frequency (Hz). The spectral density is the 
Fourier transform of the autocorrelation func- 
tion. Where the autocorrelation function yields 
information in the time domain, the spectral 
density function contains the same informa- 
tion in the frequency domain. The power 
spectrum of a purely sinusoidal signal is a 
sharp spike located in a differential interval 
around the signal frequency, i.e. Af. This 
peak occurs because all signal power is in the 
differential Af and is zero at all others. The 
other extreme is a white noise signal, which 
can be thought of as containing an infinite 
number of equally contributing sinusoidal sig- 
nals. White noise has a flat power density, 
since its power is uniformly distributed across 
the frequency spectrum. Many biomedical sig- 
nals occupy an intermediate position between 
these two extremes. 
Figure 39 shows the autbcorrelation and 
relative power functions of an ECG obtained 
during an X-15 flight at NASA’s FRC (ref. 
5 ) .  The spectral peak is %t he second harmonic 
of the fundamental R-R frequency. The main 
intelligence bandwidkh of the flight ECG sig- 
naI seems to be from about 3 to 30 Hi, 
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F K O ~ E  39.-Autocorrelation function and corresponding 
although significant noise power appears at  
frequencies as high as twice the bandwidth 
of the main intelligence. Important informa- 
tion regarding the harmonic and statistical 
structure of the ECG signal is obtained 
through the power spectral density analysis. 
I n  addition, the technique indicates the de- 
markation of signal and noise frequencies, data 
necessary for effective design of signal condi- 
tioners (see chapter 4). 
AUTOSPECTROGRAM CONTOUR MAPS 
I n  many situations, the autospectrogram 
(power spectral density) of a physiological 
signal changes with time. Describing these 
changes concisely and clearly presents a major 
r mapping technique has 
been developed by Walter and Brown of the 
Brain Research Institute (BRI) , UCLA (refs. 
6 through lo ) ,  which largely overcomes the 
difficulties associated with the presentation of 
such biomedical data. 
Figure 40 shows the construction of a con- 
tour map using EEG data taken from a nor- 
mal scalp over a period of 480 seconds (ref. 
9). The contour map is made up of a sequence 
of successive autospectrograms. The left side 
of figure 40 shows the first autospectrogram of 
the sequence, representing the first 12 seconds 
of the total period. The contour map itself is 
shown on the right side of the figure. The hoPi- 
zontal and vertical axes of the map represent 
time and frequency, respe vely. The shaded 
and cross shaded areas indicate intensity of 
the spectral density function [pV] 2/Hz). Two 
selected intensity levels are marked by dotted 
lines on the autospeotrogram. Intersections 
between the dotted lines and the autospectro- 
gram were mapped into the timefrequency 
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power spectral density function of the EGG signal. 
plane of the contour map. Repeating the same 
procedure for each successive autospeotrogram 
formed the contours shown on the map; each 
contour is loci of points of the same power 
intensity. Here only two intensity levels were 
chosen, although the number of levels is arbi- 
trary. Usually the contour intensity levels are 
selected at logarithmic intervals; in this way, 
the contours of the map represent the loga- 
rithms of power intensity. The E and L letters 
represent the highest and lowest points in their 
immediate neighborhoods. This gives the in- 
terpreter a better feeling for the mountainous 
nature of the surface. 
Figure 41 shows an EEG autospectrogram 
contour map obtained from a chimpanzee dur- 
ing 20 minutes of a Biosatellite performance 
simulation (refs. 1 and 6). The extent to which 
the EEG has been compressed in this contour 
map is illustrated by the fact that it contains 
100 autospectrograms, each requiring many 
thousand multiplications. 
Changes in the spectral intensity as a func- 
tion of frequency and time on the map can 
readily be related to the various states of the 
subject, as well as to his transition from one 
state 'to another. In  this case, it is easy to ob- 
serve that most of the power is concentrated 
below 5 Hz. The record begins with a high 
power concentration at about 2 Hz, which is 
interpreted as a drowsy state. Next the chim- 
panzee changes from drowsiness to sleep, 
which is indicated by an increase of 1- to 2- 
Hz power intensity between the ninth and 
fif,teenth minute. Finally, the chimpanzee 
awakes, as indicated by the disappearance of 
the concentrated power at  the low frequencies. 
The example shows the effectiveness of the 
intensity contour mapping technique as an aid 
to interpreting data by visual inspection. 
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FIGWEE 40.-Construction on an EEG autospectrogram intensity contour map. 
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FIGUBE 41,EEG autospectrogram contour map obtained from a chimpanzee during 20 minutes of biosatellite 
performance simulation. 
COHERENCE CONTOUR MAPS 
map is identical to 
the autospectrogram contour map, except that 
the vertical axis represents coherence instead 
of spectral intensity. The coherence contour 
map has been used by Walter and his col- 
The coherence 
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leagues to extract information regarding brain 
wave activity originating in different regions 
of the brain. This is possible because of the 
unusual properties of the coherence function. 
Basically the coherence function is a nor- 
malized cross spectral function, the magnitude 
of which varies between 0 and 1. It serves as a 
measure of interdependence of the time func- 
tion X ( t )  and Y ( t ) .  That is, if both time 
functions are random waves, having no dc 
components, and are derived from independent 
sources, the magnitude of the cross spectral 
function, as well as the magnitude of the co- 
herence function, is identically zero. The mag- 
nitude of the coherence function is defined by 
the expression : 
where : 
COH( f )  =the magnitude of the coherence 
function at frequency f ,  
MAGS (f)  =the mean cross spectral mag- 
nitude of the functions X ( t )  
and Y (  t )  at frequency f ,  
A S S  ( f )  =the autospectrum of time func- 
tional X ( t )  at frequency f, 
and 
ASY (f) =the autospectrum of time func- 
tion P( t )  at frequency f. 
It has been found empirically that a coherence 
greater than 0.5 indicates a significant inter- 
relationship between two time functions or two 
signal sources. 
Coherence function analysis has been ap- 
plied to a wide variety of EEG data at BRI 
(refs. 7, 8, and 11). Coherence plots were ob- 
tained by computing the coherence function 
for two or more wave trains over a restricted 
frequency band. These plots gave information 
regarding the phase relationship and shared 
frequencies between EEG signals originating 
\ simdtaneously in different regions of the 
brain. Relationships were obtained for a vari- 
ety of activities, leading to quantitative study 
of transitions occurring in the brain during 
tasks such as auditory vigilance and visual dis- 
crimination. Sequences of coherence plots were 
mapped inSb coherence contour maps, in the 
same fashion that autospectrograms were 
mapped into intensity contour maps. I f  inten- 
sity contour maps are available for a pair of 
simultaneously recorded wave trains, they can 
be directly transformed into a coherence con- 
tour map. 
Figure 42 shows coherence contours gen- 
erated from pairs of EEG wave trains (ref. 
9). The two arrows entering each map identify 
the contributing brain regions. The circles in 
the contours mark the time-frequency loci of 
significant coherence between the correspond- 
ing brain regions. 
Figure 43 is a sample from an analysis per- 
formed at BRI on 55 hours of EEG data re- 
corded from astronaut Borman during Gemini 
VI1 (refs. 11 and 12). Analysis included calcu- 
lation of autospectral and cross spectral distri- 
butions, as well as coherence functions. The 
map at the left shows autospectrogram con- 
tours for one EEG lead; the center map con- 
tains the same information for a second lead; 
the map at the right is a coherence plot, which 
provides information regarding the interaction 
between the two brain regions at  different fre- 
quency bands during this flight period. Results 
. pbtained from the flight data were compared, 
utilizing power spectra techniques, with base- 
line data that were collected for the same sub- 
ject in a Gemini flight simulator. The study 
revealed anticipatory and arousal states before 
launch, orientation reactions during initial ex- 
posure to weightlessness, sleep periods, and 
various other states of alertness. Note the 
“elastic” time base used in the contour plots. 
This technique allows expansion of the base to 
present selected periods of activity in greater 
detail than those of lesser interest. Greater 
compression of computed results is obtained 
without loss of significant detail. 
CONTOUROGRAPH TECHNIQUES 
The contourograph is a three-dimensional 
display that provides a perspective view of 
successive waveforms or functions in place of 
the plane view presented by contour maps. The 
technique was described by G. N. Webb at  
Johns Hopkins University (ref. 13). I n  his 
work, successive ECG complexes were recorded 
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FIGWE 42.4ontours of coherence for pairs of EEG signals. 
,slightly above one another, as shown in figure Improvements on this technique were de- 
44. The complexes were displayed on a cath- veloped by S. K. Burns et al. at the Research 
ode-ray storage tube and the tube beam inten- Laboratory of Electronics, M.I.T., under par- 
sity modulated so that it became brighter as tial NASA sponsorship * (ref. 14). These 
signal intensity within the ECG complex in- workers modified the emtourogram display 
creased. This technique created a display with 
a three-dimensional appearance of hills and 
valleys, on which it was easy to see changes in 
waveform shape, and R to R distance. 
'The research was supported by NASA (Grant 
NSG-496), National Institutes of Health (Grant 1 
PO1 GM-l49Wl),  and the Joint Services Electronics 
Program (Contract DA28-043-AMC-02536 (E)  ) . 
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FIGUBE 43.-Auto~~ectrum and coherence contours during 2% hours of Gemini GT-7 mission. 
and applied the technique to waveform aver- 
ages instead of individual waveforms. The dis- 
play mod3cation is illustrated in figure 44b. 
It involves slanting the axis representing the 
time associated with successive complexes, 
which heightens the three-dimensional quality 
of the display. 
Figure 45 is a photographic superimposition 
of 512 average click-evoked responses, rep- 
resenting the cortical potentials of a rat. Each 
of the average responses was computed from 
120 evoked potentials. To provide a “smooth” 
transition from one average to another, a 
“moving average” technique was employed. 
That is, each average of 120 responses was dis- 
placed by an interval corresponding (to only 15 
responses from the preceding average. I n  this 
fashion, 105 of the evoked potentials included 
in each average also enter into the adjacgnt 
one. The “smoothness” of the surface can be 
controlled by varying the amount by .ui;hich ad- 
jacent averages of the signal complexes over- 
lap. Chlorpromazine was administered at the 
point marked by an arrow; th6 subsequent 
change in cortical potential is distinctly seen. 
The contourogram technique is widely appli- 
cable and could, in fact, be used with the 
power spectral density or coherence plots dis- 
cussed earlier. 
ADDITIONAL CONTRIBUTIONS 
NASA’s concern with increasing ,the amount 
of physiological information extracted from 
noise-degraded signals has brought about sev- 
eral improvements in signal processing tech- 
niques. The ECG preprocessing unit and the 
cardiac and respiration monitors briefly out- 
lined below are a result of NASA’s efforts in 
this area. Improvements in signal processing 
have been supplemented by improved analysis 
techniques, many of which were presented in 
previous sections of this survey. The addition- 
al contribution presented here deals with the 
first and second derivative of rate data, such 
as heart rate and respiration rate. 
(1) An eleotrocardiogram preprocessing unit 
was developed for NASA at the Texas Insti- 
tute for Rehabilitation and Research (ref. 15). 
This unit provides a fixed pulse output for each 
heart beat and is unresponsive to a wide variety 
of false trigger signals. Consequently, the unit 
is useful where electrocardiograms are associ- 
ated wi&h noise caused by subject exercise, 
flight conditions, or other disturbances. 
The pulse output of the unit can be used as a 
trigger for a cardiotachometer circuit, or can 
be digitized and fed into a computer for 
further analysis. Figure 46 shows the block 
diagram of the electrocardiogram processing 
unit. The input signal is fed to a bandpass fil- 
ter which is tuned to the frequency of the QR8 
complex and rejects frequency components re- 
sponsible for noise and adifacts. The signal is 
then processed through a hybrid full-wave 
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output. I n  this case, &he pulse output is not 
affected by the slow wave artifact present in 
the ECG; this is caused by the filter which re- 
duces the artifact to an amplitude insufficient 
to !trigger the multivibrator. 
(2) Advanced cardiac and respiration rate 
monitors for use on Gemini spaceflights were 
developed and fabricated for NASA by Ben- 
dix-Pacific Division (ref. 16). The monitors 
provide instantaneous heart rate, instantaneous 
respiration rate, and average respiration rate. 
Values are displayed on analog meters and re- 
corded on strip chants. Signal preprocessing is 
carried out in a manner like that described for 
the preprocessing unit above. These monitors 
have a novel circuit feature: an active, non- 
linear filter and integrator. The combined ef- 
fect of these circuits is to reduce effects caused 
by discontinuity of signal resulting from loss 
of telemetry and other artifact noise. 
(3) The time rate of change of such derived 
variables as heart rate and respiration rate is 
of interest in medical monitoring. I n  comput- . 
ing this quantity, however, conventional differ- 
* 
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FIQWE 44.-Contourogram display techniques. 
rectifier, which triggers a one-shot multivi- 
brator circuit to give a pulsed output. 
47 shows an ECG wave before 
ing and after filtering, and the resulting pulse 
FIQWBE 45.4ontourogram display of average evoked 
cortical potentials of partially restrained rat. 
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FIGURE 47.-Response of the Texas Institute EGG 
preprocessor to a slow wave artifact. 
entiation (from the calculus) has to be modi- 
fied. This is because differential calculus as- 
sumes continuous measurements, which is not 
the case in heart rate and respiratory rate de- 
terminations and also because it is difficu1.t to 
fit smooth curves to the irregular instantaneous 
rate data. According to J. F. Lindsey (ref. 1) , 
studies carried out at NASA by J. C. Town- 
send (refs. 1’7 and 18) show how to apply 
differentiation procedures to variables such as 
hear.% rate or respiration rate. The procedures 
yield rate of change and rate of rate of change, 
which can be used as new physiological pa- 
rameters. These parameters are reported to be 
sensitive indices of astronaut adaptability to 
spaceflight conditions. 
APPLICATlON EVALUATION 
Current technology has made it relatively 
simple for the biomedical investigator to col- 
lect floods of data. Accordingly, automated 
techniques for condensing, summarizing, and 
extracting hidden information from these data 
have become essential. NASA contributions to 
data analysis in bioinstrumentation systems 
apply directly to two major areas of clinical 
medicine : mass data processing and automated 
signal analysis. These areas share the objective 
of revealing aspects of the data not immedi- 
ately obvious to the physician. Both are steps 
-€@ward automated diagnosis and thus are 
closely connected to such new medical tech- 
niques as intensive care monitoring, continuous 
monitoring of ambulatory heart patients, mul- 
tiphasic testing, etc. 
To a large extent, however, many of the 
techniques discussed in this chapter and in the 
preceding chapter depend on the digital com- 
puter. While the value of computers in all 
phases of medicine is unchallenged today, a 
majority of the medical community remains 
outside the computer fold. This is mainly be- 
cause previous development has centered on 
large, high-powered, and expensive computer 
installations, like those at  Manned Spacecraft 
Center and many universities. The recent ap- 
pearance of small, fast, and relatively inex- 
pensive computers promises to extend the bene- 
fits of automatic data processing. I n  particular, 
the small computer appears well suited to the 
various hospital subdivisions which have found 
computer use uneconomical up to now. Its 
introduction may greatly extend the direct ap- 
plication of many of NASA’s contributions. 
A small computer is defined as such on the 
basis of its data processing capacity, data stor- 
age capacity, and price. With modern circuit 
construction techniques, it may generally be 
small in size. Compared to the more powerful 
computers, the small machine (1) utilizes a 
shorter word length (i.e., numbers are carried 
to less signihant figures) ; (2) is limited in the 
number of operations it can do simultaneously; 
and (3) provides a smaller fast memory. The 
operation of small and large computers is sim- 
ilar; the small computer may perform its con- 
stituent arithmetic operations nearly as fast as 
the big machines and match them in program- 
ming sophistication. 
The combination of adequate storage capa- 
bility and high computing speed makes the 
small computer attractive in many biomedical 
data processing situations. For example, an- 
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alysis has shown that &he small computer can 
effectively handle advanced monitoring opera- 
tions in the surgical recovery unit and such 
special situations as shock management (see 
ref. 11, chapter 5 ) .  Small special-purpose com- 
puters have been constructed to provide con- 
tinuous auto and cross correlation, as well as 
spectral analysis, indicating that this type of 
operation is also possible on the small, general 
purpose, programmable machines. 
Advanced NASA data handling and proc- 
essing techniques described in the last two 
chapters may soon be applied to nonaerospace 
situations at  reasonable cost. The transition 
from large-computer to small-computer im- 
plementation of these techniques will be lim- 
ited only by the imagination of bioinstnunen- 
tation system designers. 
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CHAPTER 7 
Advances in Measurement Technique for Use in the Field 
NASA has sought laboratory-quality meas- 
urements under field conditions. Thus, in a 
sense, most of the NASA-sponsored bioinstru- 
mentation represents advances in field meas- 
urement technique. Several developments, 
however, are outstanding ; some because they 
bring to field observation methods formerly 
available only in the laboratory, and some 
because they demonstrate the solution of par- 
ticularly difficult measurement problems. 
Three examples are presented in this chap- 
ter. The flight adaptation of impedance pneu- 
mography for respiratory recording illustrates 
a two-phase attack, through scientific research 
and equipment design, on a basic biomedical 
measurement problem. The. NASA spray-on 
eleotrodes illustrate a novel approach to sensor 
attachment obstacles encountered in an ambi- 
tious and successful program of pilot monitor- 
ing. Finally, development of the in-flight mass 
spectrometer represents an engineering tour- 
de-force, which potentially brings a valuable 
laboratory analytical technique to the field 
environment. 
IMPEDANCE PNEUMOGRAPHY 
When planning spaceflight monitoring, 
NASA recognized the need for cont' I inuous 
respiratory data as an indication of physio- 
logical condition. Available techniques such as 
pneumographs, pneumotachographs, spirom- 
eters, strain gage devices, or thermistor sensors 
were either unreliable or encumbering. Ac- 
cordingly, NASA turned to the then little- 
known technique of impedance pneumogra- 
phy. Through continual study, evaluation, and 
engineering development, this method was im- 
proved to the point of successful application 
under the most arduous flight conditions. 
Impedance pneumography constitutes an in- 
direct means of measuring respiratory volume. 
The method is based on the observed relation- 
ship between transthoracic impedance and the 
volume of inspired air. During respiration the 
many tissues of the thorax, which include fat, 
muscle, fluids and lung tissues, are stretched, 
and the electrical impedance of the thorax 
changes. I f  a constant current is introduced 
into the tissues, the voltage drop across the 
thorax will fluctuate together with the respira- 
tory movements. This phenomenon was ob- 
served as early as 1935 and has since been 
studied by a number of investigators (ref. 1). 
Although the exact cause of the impedance 
change is still unknown, a good deal of em- 
pirical data has been acquired that permits 
fairly confident instrumentation design. 
This measurement method does not require 
that the patient wear a facemask. Nor is a 
separate air system needed. The technique is 
insensitive to changes in barometric pressure, 
temperature, or gravitational forces. Trans- 
ducers consist simply of a pair of eIectrodes 
located on both sides of the thorax, such that 
an electrocardiogram may also be obtained 
from the same electrodes (ref. 2). 
A representative impedance pneumograph 
is shown in figure 48. The equipment consists 
of three circuit modules: an oscillator, an am- 
plifier, and a demodulator. The input termi- 
nals a and b encompass an overall impedance 
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T = COUPLINO TRANSFORMER 
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D = DEWDULATOR 
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FIGWE 48.-Impedance pneumograph block diagram. 
2, + AZ. 2, represents the transthoracic im- 
pedance measured at rest, and AZ represents 
the impedance change during respiration. The 
output voltage of the oscillator is applied 
across the subject's thorax and the transformer 
input. I f  the output impedance of the oscilla- 
tor is much grearter than Z+AZ, then the volt- 
age drop across the transformer is a function of 
thoracic impedance, 2 + AZ. Fluctuation in 
thoracic impedance modulates the oscillator 
signal. The modulated signal is amplified by 
the tuned amplifier and demodulated, yielding 
an analog representation of respiratory move- 
ment. The two basic variables in this system 
are the frequency of operation and the location 
of the electrodes on the subject. 
A study of the parameters involved in pneu- 
mographic measurements (ref. 3) indicates 
that the frequency of the applied current must 
be high enough to avoid stimulating the sub- 
ject; khat is, it should be well above the high- 
est frequency found in bioelectric signals. Ex- 
periments showed that pneumograph measure- 
ment can be made over a range from 20 to 100 
kHz. It was found that the placement of the 
electrodes on the chest determines the amount 
of impedance change sensed during each 
breath. Moreover, location of the electrodes 
close to the sixth rib yields the highest im- 
pedance change per breath and, therefore, is 
most suitable for pneumographic recording. 
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FIGWE 49.-Simultaneow tracings of respiratory vol- 
ume and transthoracic impedance for a seated male 
subject. 
A NASA-sponsored study at  Baylor Uni- 
versity quantitatively determined the relation- 
ship between the variation in transthoracic im- 
pedance during respiration and the volume of 
inspired air (ref. 4). A typical impedance 
volume record is shown in figure 49. A large 
number of such records was obtained at  fast 
recording speeds; no lag was observed be- 
tween the fluctuation of volume WAV and im- 
pedance, AZ. Using random samples of A B  and 
AZ, correlation coefficients, regression lines, 
and standard errors were calculated. The data 
indicated a close correlation between the physi- 
cal measurements of the subject, such as size, 
and weight, and the ratio AZ /AV. The study 
concluded that knowing these measurements 
one can determine the volume of inspired air 
within k0.166 liter in 95 out of 100 cases. 
The relationship between the transthoracic 
impedance and the impressed current fre- 
quency was examined in the same study, Data 
were obtained from a single subject with elec- 
trodes placed on the midaxillary line at the 
xiphoid level. Resting expiratory level (Zo) 
decreased with increasing frequency through- 
out the range of 50 to 600 kHz. However, 
through this range the fluctuation of im- 
pedance caused by inspiration was constant at 
23 ohms. Thus, it appeared that A Z  was fre- 
quency independent and that the fluctuation 
in the impedance is basically resistive. 
The firkt NASA impedance pneumograph 
system was developed by McDonnell Aircraft 
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Corp. on the basis of the work done by Geddes 
and his colleagues at Baylor University. The 
components of the McDonnell pneumograph 
were located beside the pilot and were con- 
nected to the electrodes by wire. This system 
wtts used throughout the Mercury program, 
starting with the second flight. Although the 
system produced excellent impedance record- 
ings, it had some shortcomings in flight be- 
cause of noise pickup by the electrode leads. 
The problem was solved in the NASA-spon- 
sored development of a miniaturized imped- 
ance pneumograph signal conditioner (see 
chapters 4 and 8). The signal conditioner 
weighed 50 grams and was mounted inside the 
pilot’s suit. The operating frequency of this 
system was set at 50 kHz. I n  use, electro- 
cardiogram signals were recorded from the 
same electrodes. The EGG signals were ob- 
tained at a frequency of 320 samples/sec and 
passed through a lowpass amplifier with an 
upper frequency limit of 100 Hz. The new in- 
strument was used successfully on the Gemini 
flights and has been further improved for the 
fohhcoming Apollo program. To date, how- 
ever, NASA has depended on the impedance 
pneumograph for qualitative rather than 
quantitative indications of respiratory vol- 
ume. This is because the conditions of long- 
term spaceflight preclude optimal electrode 
placement and the necessary calibration of the 
impedance signals. 
SPRAY-ON ELECTRODES 
The objective of a project at the NASA 
Flight Research Center at Edwards Air 
Force Base, is to obtain in-flight physiological 
information daily on students at the USAF 
Aerospace Research Pilot School. To do this, 
(the student pilots must be quickly prepared 
for ECG recording “on the run,” as they enter 
their aircraft. The electrodes used must oper- 
ate reliably under the flight conditions and 
must not interfere in any way with the move- 
ment or comfopt of the pilot subject. The re- 
quirements specified were (ref. 5 )  : 
(1) Neither the electrodes nor the electrode 
wire should be felt by the subject. 
(2) Electrodes must be resistant to motion 
artifad. 
(3) Skin irritation must not result from 
frequent application of the electrodes. 
(4) Shaving must not be a part of the pro- 
cedure of applying electrodes. 
( 5 )  Application of an electrode should take 
less than 30 seconds. 
Ah the Flight Research Center, these re- 
quirements were met by the development of 
novel spray-on eleotrodes, which resist motion 
artifact and can be applied to the skin in a 
relatively short time.’ The electrodes are com- 
posed of an air-drying, electrically conductive 
cement that can be applied to the skin by zb 
spray gun or an aerosol process. The conduc- 
tive cement is a mixture of a commercially 
available household cement, silver powder, and 
acetone (refs. 5,6,  and 7).  
Figure 50 illustrates the steps in applying 
a spray-on dry electrode. The spray gun (A)  
is a modified atomizer assembly with two 
valves and a glass container for the liquid 
cement mixture. An air hose in khe spray gun 
is used to dry the cement. A special barrel (B) 
with a slit tab on the end holds the fine elec- 
trode lead, which is disengaged by a spring- 
loaded release rod. The barrel confines applica- 
tion of the conductive cement mixture ,to a 
circular area the size of a half dollar. A simi- 
lar barrel has been fabricated to fit aerosol 
cans filled with the conductive spray mixture 
(C). For effective application of the elec- 
trodes, the selected skin area must be cleaned 
with an electric toothbrush and electrode jelly 
(D). The residual jelly is then removed and 
a fresh thin film of jelly is wiped onto the 
prepared skin area. Conductive cement is 
sprayed over the jelly film to capture an end 
of the lead wire and to form the circular 
electrode on the skin (E). The electrode is 
finally air dried and coated with commercially 
available insulating cement released from an 
aerosol can (F)  . The finished electrodes are 
shown in figure 51; they are less than twenty 
thousandths of an inch thick, and their con- 
‘In a cooperative effort of NASA personnel ana a 
field team from Spacelabs, Inc. 
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FIGUBE 5O.-Steps in the application of NASUFRC spray-on electrodes. 
necting wires are approximately the diameter 
of a human hair. 
Experience to date has shown that the time 
required to connect one spray-on electrode to 
the subject is 20 seconds; complete attach- 
ment of three electrodes routikely takes only 
about 3 minutes. This is quite short in com- 
parison to the time required to attach conven- 
tional electrodes. Skin shaving is not required 
before the electrodes are applied. Spray-on 
electrodes have been attached to several hun- 
dred subjects, and no cases of skin irritation, 
folliculities, or contact dermatitis have been 
noted (ref. 5 ) .  I n  addition to recording well 
over 1200 hours of data (as of August 1966) 
at the Flight Research Center, the dry elec- 
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FIGURE 5l.-NASA/FRC spray-on electrodes after 
application. 
trodes have been used to obtain heart rate data 
from Navy carrier pilots in combat over Viet- 
nam (refs. 8 and 9). 
The major disadvantage of the dry elec- 
trodes is their high impedance, which ranges 
between 75 and 100 kilohms. High impedance 
increases the susceptibility of the monitoring 
system to noise, reduces the gain of the system, 
and attenuates the low frequency components 
of the recorded signal. A high inpnt imped- 
ance amplifier overcomes most of these difficul- 
ties. Experiments' have indicated that an am- 
plifier input impedance of at least 2 megohms 
is necessary to reproduce the ECG waveform 
without distortion (ref. 5 ) .  With such an am- 
plifier, ECG tracings, as illustrated in %re 
52, equal those obtained with conventional wet 
electrodes. Figure 52 also indicates that the 
dry electrodes are suitable for impedance 
pneumography. 
MINIATURIZED MASS SPECTROMETER 
Another developmental program sponsored 
by &he NASA Flight Reseach center is for 
the constmotion of a small mass spectrometer, 
capable of use in a high-performance aircraft 
or a space capsule (ref. 10). The objective of 
the program is to permit analysis of expired 
gases, particularly alveolar samples, under 
dynamic field conditions. It is part of a gen- 
eral NASA effort directed toward improving 
existing gas sensors such as the polarographic 
O2 sensor and the infrared CO, sensor. How- 
ever, these sensors are restricted to specific 
gases, and generally are limited in their time 
of response to changes in gas concentration. 
The mass spectrometer, on the other hand, 
is characterized by an inherently rapid re- 
sponse. This is highly useful for breath-to- 
breath recording (ref. 9), since the partial 
pressures of O2 and CO, change rapidly 
throughout a single breath. Also, in normal 
individuals the O2 and the CO, partial pres- 
sures during the last l/lOth of a second of a 
F I Q ~ E  52.-Tracings obtained with NASA/ITRC spray-on electrodes. 
72 BIOINS!I!RUMENTATION SYSTEXB 
single expiration will closely approximate those 
of the alveolar air and, accordingly, those of 
arterial oxygen and carbon dioxide. To detect 
the alveolar O2 and COz pressures continu- 
ously and accurately, it is necessary to per- 
form the entire gas analysis within the critical 
period of 0.1 second-a requirement that can 
readily be satisfied by the mass spectrometer. 
The ability of the mass spectrometer to ana- 
lyze many gases simultaneously gives it the 
added feature of detecting and measuring 
gases whose presence might be unanticipated 
or unknown. 
The mass spectrometer analyzes a gas mix- 
ture by separating it into its components on 
the basis of mass; chemical properties are not 
utilized. A wide variety of mass spectrom- 
eters has been developed. They differ in physi- 
cal structure and in mass detection configura- 
tions ; khe operating principle, however, is the 
same. I n  each, gas molecules are converted to 
positive ions and accelerated by the applica- 
tion of an electric field. Then, one of several 
methods is applied to a trajectile movement 
path. The various ions are split into differ- 
ent trajectories according to their mass-the 
heavier ions having the longer paths. At the 
end of their trajeotories, the ions of each mass 
group impinge on separate collector buckets, 
producing an electrical current in proportion 
to their concentrsution in the sample. 
The basic problems in adapting mass spec- 
itrometry to in-flight gas analysis are weight 
and size. Commercial mass spectrometers nor- 
mally weigh several hundred pounds and 
occupy a good part of a laboratory room. 
These difficulties were overcome in lthe minia- 
ture, double-focusing mass speotrometer de- 
veloped to the specifications of the NASA 
Flight Research Center (ref. l l) .z The 
NASA/FRC instrument weighs 28 pounds, 
measures 10x11 x 11 inches and, for its space 
applications, requires no vacuum pump 
(which, in the atmosphere, is needed to main- 
tain low pressure within the unit). The instru- 
ment is capable of simultaneously monitoring 
12 gases, over the range mass 3 to mass 100. 
a The unit was developed and constructed for NASA 
by Consolidated Systems Corporation, Pomona, Calif. 
FIGURE 53.-NASA/FRC miniature mass spectrometer. 
Figure 53 shows the instrument as delivered 
to FRC; a simplified block diagram is pro- 
vided in figure 54. By electrically opening one 
of the inlet valves, a sample is selected and a 
gas flow is established from &he sample source 
through the capillary lines, the inlet manifold 
and the gold leak, to  the ion source. The ion 
pump removes some of the molecules in order 
to maintain pressure below ambient. An elec- 
tron beam in the ion source ionizes a small 
number of the molecules. Under the influence 
of an electric field, part of the ionized mole- 
cules &ravel out of the ion source ithrough the 
energy filter into the magnetic seotor, the 
region where they are acted upon by a mag- 
netic field. 
The magnetic field is perpendicularly ori- 
ented to the velocity vector of the ions and 
creaks a force that aots upon the particles in 
a direction perpendicular to both their velocity 
and the applied magnetic field. The resultant 
movement path is a circle with a radius di- 
rectly proportional to the panticle mass. The 
ion beam that passes lthe energy filter consists 
of ions of all gases in the sample. Upon enter- 
ing the magnetic sector, the beam is split into 
the various trajeotories with different radii. 
Collector buckets are located at  varying dis- 
tances, each collecting ions of a different mass. 
Continuous measurement o f  the current at 
each bucket yields the partial pressures of the 
various gases present. 
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FIGTJXE M.-Block diagram of NASA/FRC mass spectrometer. 
The double-foeusing mass spectrometer was 
evaluated in a 1-year program at the NASA 
Flight Research Center (ref. 12). The instru- 
ment underwenh flight testing as well as 
ground evaluation for stabili&y of perform- 
ance, response time, and reliability. I n  the 
stability experimenh the output of the 0, 
channel was plotted continuously at a constank 
input pressure. Over a 3-hour 'test period the 
output remained within k2.5 percent of the 
standard value. The accuracy of the system 
was ensured by periodic calibration of the 
entire system against samples of a known gas 
mixture. (Under operating conditions an auto- 
matic calibration. is performed every 2 min- 
The response time of the instrument was 
found to vary from 30 to 100 milli seconds 
depending on channel sensitivity. Response 
utes.) 
time was determined by injecting a known 
sample and measuring the time elapsed until 
the output had reached 99 percent of its final 
value. The instrument appeared to be reliable 
and no attention was required in continuous 
operation, other than replenishment of the 
liquid nitrogen in khe absorption pump. The 
power requirement of the instrument tested 
never exceeded 50 wafts, with a 28-t-4 Vdc 
input voltage. The primary environmental 
limitation was temperature range, which was 
found to be + 6 O  C about the ambient temper- 
ature. (The magnet was temperature-sensitive 
over a broader temperature range.) In-flight 
operation, with maneuvering loads up to 6G 
and rapid attitude changes, did not alter the 
performance of the instrument. The original 
unit is now at FRC undergoing additional 
tests and refinements. 
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APPLICATION EVALUATION 
The technique of impedance pneumography, 
greatly refined by NASA, offers a new poten- 
tial for telemetric recording of respiratory 
movement and volume. It can be used in a 
variety of situations where the activity of the 
subject should not be restricted; and such 
applications have already begun to appear in 
the clinical literahre. One interesting applica- 
tion of the methods, described by Pallet et al. 
(ref. 13), is in respiratory recording of new- 
born babies, where traditional recording tech- 
niques adversely restrict the child's aotivity or 
increase resistance to breathing. Sargenk and 
Robertson report another clinical application 
(ref. 14), in which the impedance pneumo- 
graph signal is used to trigger an x-ray unit 
at a specific respiratory phase. The impedance 
pneumograph also has potential for detecting 
neurological breathing difficulty in patients 
under acute stress such as after an operation 
or cardiovascular accident; it is thus well 
suited to the needs of intensive care monitor- 
ing. Finally, the impedance pneumograph is 
useful wikh experimental animals, because 
even small ones are not constrained by its 
application. The NASA-developed techniques 
need little or no modification for nonaerospace 
applications. 
Spray electrodes have a potentially wide ap- 
plication in cases where electrodes are used 
routinely, for reasonably long periods, or on 
active subjects. The major advantages are : (1) 
rapid application, (2) comfort in use, (3) 
freedom from motion artifacts, (4) durability, 
and ( 5 )  low cost per application. I n  addition 
to the aircraft recording situations cited (refs. 
8 and> 9), the dry electrodes have been used 
successfully on active children. 
The general conclusion drawn from NASA's 
evaluation was khat the double-focusing mass 
spectrometer shows considerable promise as a 
practical means of respiratory gas analysis in 
the inflight environment. The simplicity of 
operation, accuracy, and stability of this mass 
spectrometer make it highly suitable, too, for 
clinical work, particularly where portability is 
an advantage. Because it is capable of continu- 
ous monitoring of the partial pressures of sev- 
eral gases, another application for the device is 
suggested. The double-focusing mass spec- 
trometer could conceivably add significant 
quantitative dimension to the clinical practice 
of anesthesiology, in which monitoring of 
several anesthetic gases is necessary. I n  addi- 
tion, the rapid response time of the mass spec- 
trometer makes it the instrument of choice in 
determining cardiac output by indirect Fick 
methods, such as CO, rebreathing. 
Each of the three NASA contributions de- 
scribed in this chapter is, or will soon be, 
commercially available. Several bioinstrumen- 
tation firms are offering impedance pneumo- 
graph units that incorporate NASA-sponsored 
advances. A commercial version of the NASA- 
initiated miniaturized mass spectrometer is 
available. Development and market penetra- 
tion of the NASA/FRC spray-on electrodes 
has been undertaken under a separate NASA 
contract. 
Even when current applications are some- 
what limited, an outstanding device may well 
be marketed speculatively to investigators. To 
some extent, this is now occurring with ultra- 
sonic blood flowmeters and biotelemetry im- 
plants, instrumentation whose development 
NASA has also promoted. 
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CHAPTER 8 
Spaceflight Bioinstrumentation Fabrication 
This chapter describes a number of manu- 
f aoturing and quality assurance techniques 
used $0 meet rigorous environmental stresses 
without sacrificing size, weight, power, or per- 
formance. The discussion focuses on the flight 
safety system-the sensors, signal condi- 
tioners, and wiring harness worn by the astro- 
naut under his spacesuit. Figure 55 shows the 
components of the Gemini flight safety system. 
The Apollo system is much the same physi- 
cally, while in the Mercury system, the signal 
conditioners were not placed within the space- 
suit. Aside from the voice communication 
gear, the flight safety components provide the 
primary indicsution of the astronauks’ well- 
being in space (ref. 1). 
BYQUEE 55.-Sinal conditioners and connector harness 
for the Gemini biomedical flight safety system. 
For the flight bioinstrumentation, the re- 
quirement of minimal failures was refleoted in 
stringent environmental operating specifica- 
tions, going far beyond .those normally asso- 
ciated wikh medical equipment. The specifica- 
tions were generaked not merely as an exercise 
in reliability assurance, but in response to the 
anticipated contingencies of spaceflight. These 
include vibration, impact, and acceleration 
stresses at  lift-off and reenkry, pure oxygen 
atmosphere, depressurization, high humidiity, 
and temperature in the capsule or close to the 
astronaut’s body, weightlessness, and even the 
possibility of salt spray or sea water immer- 
sion during ocean recovery. 
FLIGHT SIGNAL CONDITIONER 
From lthe standpoint of systems design, the 
flight signal conditioners presented the most 
dScult  fabrication problem. Electronically 
complex, these units had to be small enough to 
fit unobtrusively under the spacesuit and 
rugged enough to withstand the environmental 
extremes of spaceflight. Moreover, the state of 
teGhnology a t  the time the units were designed 
and manufaotured limited them to miniature, 
discrete electronic components, instead of 
microminiature integrated circuits of thin film 
elements. 
Accordingly, both the Gemini and Apollo 
signal conditioners employed welded cord- 
wood construction to achieve high component 
density and high reliability. In  this technique, 
small electronic components (resistors, capaci- 
tors, transistors, etc.) are sandwiched between 
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FIGUBE 56.-Mylar film template 
plastic templates. The component leads are 
brought through the plastic and welded, 
rather than soldered. When packaged and en- 
capsulated, the resulking units are virtually 
solid and highly resistant to environmental 
stress. 
The first step in the produotion of a signal 
conditioner is the photographic preparation 
of a set of actual size, transparent, Mylar tem- 
plates. An example is shown in figure 56. On 
these templates are printed part locations and 
the welding ribbon interconnects. The printed 
wire paths act as guides to the worker, helping 
eliminate connection assembly errors. Fabri- 
cation steps are shown in figure 57. The tem- 
plate is punched (A) to provide holes for 
inserting the component leads and for position- 
ing i,t on assembly fixtures. After the “front” 
and “back” pieces are attached to an assembly 
fixture, the components are inserted between 
them (B) in much the same way that a clock- 
maker assembles the gears of a clock between 
two brass plates. 
used to position signal conditioner components. 
The Mylar sheets are next pushed together, 
and the two portions of the assembly jig 
secured. An operator welds the positioned 
components utilizing a stereoscopic micro- 
scope and a special, parallel-gap welding ma- 
chine (C). Patience and dexterity are re- 
quired, and the machine must be carefully 
adjusted to yield an optimum connection. At 
this point, with the circuik partially com- 
pleted, specialized or matched components are 
selected and installed. The completely welded 
electronic unit (D) is next removed from the 
welding jig and the Mylar sheets are trimmed. 
The signal conditioner ah this point contains 
all of its components, including connectors. 
The electronic assembly is slipped into a 
hydro-machined, thin-walled, anodized alumi- 
num case. An opaque, glass-filled epoxy is then 
slowly introduced into the case (E) and is 
allowed to solidify under heat. The epoxy pro- 
vides electrical isolation for the closely packed 
components and mechanical strength and 
rigidity for the completed circuit assembly. 
a 
FI~WBE 67.4ignal conditioner fabrication. (a) 
punching Mylar fllm; (b) component installation; 
(c) parallel gap welding-unit is positioned in a 
welding jib; (d) welded unit; (e) epoxy encapenla- 
tion. 
b 
d 
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e 
FIGURE 58.--Completed Apollo bioinstrumentation 
signal conditioner. 
The temperature coefficient of expansion of 
the encapsulating epoxy is matched to the 
average coefficient of the electronic compo- 
nents so that subsequent thermal exposures of 
the signal conditioner do not cause internal 
mechanical stresses. Finally, the nameplate is 
attached to the case, and the completed signal 
conditioner is ready for acceptance and quali- 
fication testing (fig. 58). The Apollo signal 
conditioner modules weigh 30 to 50 grams, 
depending upon type, and occupy about 20 
cubic centimeters, or 1.3 inches. 
QUALITY ASSURANCE 
Spaceflight is tihe ultimate test of space bio- 
instrumentation. Yet equipment destined for 
space must be accepted by NASA on the basis 
of nondestructive terrestrial examination. To 
assure that the end items for which it con- 
tracted would perform flawlessly, NASA has 
established an exacting set of quality assur- 
ance provisions. "hese specify quality control 
procedures for fabrication of the deliverable 
end items, such as the various signal condi- 
tioners, and also provide guidelines for quali- 
fication testing. The provisions are stated 
broadly in NASA quality assurance docu- 
ments (refs. 2, 3, 4), and specifically in con- 
ltract work statements. Drawing heavily on 
previous DOD experience (ref. 5 ) ,  they are 
adapted to the unique requirements of space- 
flight. For major deliverable items, ;they en- 
sure close interaction of NASA quality assur- 
ance personnel with the contractor's quality 
assurance, design, and production engineers 
throughout the development program. 
The Apollo flight signal conditioners once 
again provide an example of procedure. After 
the design of a specific signal conditioner was 
fixed, quality control during fabrication de- 
pended upon a detailed inspection plan pre- 
pared by the contractor and approved by 
NASA. 
ACCEPTANCE TESTING 
Each Apollo signal conditioner fabricated 
was subjected to an extensive series of accep- 
ltance tests, that certified its ability to meet key 
operating specifications. The acceptance tests 
were conducted in the contractor's facility, for 
the most part under standard laboratory en- 
vironmental conditions (an exception was the 
in-line temperature test). 
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TABLE 7.-Typical Electronic Acceptance Test Schedzcle 
for the Apollo Signal Conditioner 
Test Function 
Operation 
time 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
26 
26 
27 
Product examination 
Identification 
Sise 
Weight 
Connectors 
Controls 
Workmanship 
Finish 
Color code 
Burn-in test 
At 0 hr. 
16 through 32 hr. 
After 50 hr. 
Output dc bias 
Input current 
Output resistance and parallel operation 
Frequency response 
Gain 
Input impedance 
Noise 
Recovery time 
50-kHz rejection 
Common mode rejection 
Power input current 
In-line temperature (-20" C, +70° C) 
Initial gain 
Gain 
Output dc bias 
Noise 
Common mode rejection 
70 hr. 48 min. 
10 min 
10 min 
10 min 
10 rnin 
20 min 
20 min 
20 min 
10 rnin 
10 min 
20 rnin 
10 min 
45 rnin 
Total 74 hr 18 min 
Table 7 presents the acceptance test sched- 
ule for the Apollo ECG signal conditioner, 
and figure 59 illustrates the data sheet associ- 
ated with one particular test. The data sheet 
.records the test results, the &est equipmenk 
used, and the joint acceptance of the test by 
quality control personnel from the contractor 
and from NASA. An acceptance data package 
about 25 pages long accompanied each deliv- 
ered signal conditioner. After acceptance by 
NASA, a historical record is established, 
which provides a chronological listing for 
each signal conditioner of acceptance, deposi- 
tion, tests performed, modifications, and 
cumulated operating b e .  
QUALIFICATION TESTING 
Two complete Apollo safety bioinstnunen- 
tation systems were subjected to flight qualifi- 
cation testing. Flight qualification represents 
a punishing series of adverse environmental 
exposures. Its purpose is to validate the basic 
system design and ensure its operation under 
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ACCEPTANCE TEST PROCEDURE 
3.2.5 INPUT VOLTAGE AND CURRENT AND OUTPUT REGULATION TEST 
3.2.5.1 TEST SETUP 
3.2.5.2 TEST FUNCTIONS 
ABOVE VALUES WITHIN TOLERANCES ACCEPTED REJECTED 
Q.A. STAMPS 
TEST EQUIPMENT 
+16.8 V (a) POWER SUPPLY, H/L 865-, SERIAL NO.-, CAL.DATE:- 
(b) AMMETER, HP 4l2A, SERIAL NO.-, CAL. DATE: 
(e) DIGITAL VOLTMETER, HP3440A, SERIAL NO.-, CAL. DATE:- 
TOTAL OPERATING TIME MINUTES 
Q. A. STAMPS 
FIGUBE 59.-Typical acceptance test data sheet. 
space conditions. Qualification testing was sequence for the Apollo flight safety bioinstru- 
carried out in the facilities of a subcontractor, mentation system. Systems I and I1 were iden- 
following a plan agreed upon, and witnessed tical but traversed different routes in the quali- 
by contractor and NASA inspection personnel. fication procedure. The points marked <‘B”’ on 
Figure 60 outlines the qualification test the diagram represent functional tests of the 
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Unit 
ZPN 
EGG 
Temp & 
probe 
&/de 
converter 
entire system, undertaken between each indi- 
vidual qualification test; the points marked 
“OP” represent operational tests, undertaken 
during the qualification test conditions them- 
selves. The functional and operational tests 
are briefly described below, along with ithe 
qualiflcation test conditions. 
(1) Functional test. functional test is 
designed to demonstr syBtem is per- 
forming within specifie ts. It involves a 
check of several key parameters for each elec- 
tronic system component. Table 8 summarizes 
the measurements made. 
( 2 )  Op&ationaZ test. The routine opera- 
tional test, summarized in table 9, involves an 
abbreviated set of checks and is made at  speci- 
fied times during each environmental test. 
The following represent the qualification 
test conditions. 
(1) Compatibility. System components are 
doubled or interchanged, and functional oper- 
ation is checked. 
(2) EruZurance. The system is operated at 
120’ F for 366 hours. 
(3) Voltage vuriatwn. Conducted sepa- 
rately on the different signal conditioners, this 
test checks the effect of variations in supply 
voltage. 
(4) Susceptibility. The system is exposed 
to conducted and radiated external interfer- 
Functional test data 
Electrode current, supply frequency, 
output bias, gain 
Output noise, output bias, common 
mode rejection, gain 
Functional accuracy 
Regulation 
ence signals in ithe audio and radio frequency 
range. 
(5) High temperature. The system is oper- 
ated at  160’ F for 48 hours, and is checked for 
(7) Oxygen atmosphere. The system is 
operated in a 100-percent oxygen atmos- 
phere at  ambient pressure and temperature for 
40 hours. During &he final 2 hours, tempera-. 
ture is increased to 160’ F. Checks are made 
for burning, creation of toxic gases, obnox- 
ious odors, or deterioration of seals. 
(8) Pressure. The system is operated at 1.0 
psia and 160’ F for 65 hours. It is checked for 
crushing, distortion, opening of seals, etc. 
(9) Salt  spray. The system is suspended in 
a salt spray chamber and sprayed with saline 
for 48 hours. 11 is inspected for physical 
degradation and then functionally tested. 
( I O )  Immersion. The energized system with 
harness connectors &&ached is immersed in un- 
treated natural human urine for 2 hours. It is 
de-energized and dried in an atmosphere of 
100-percent oxygen, 5 psia, and 160’ F. For 
the nexh 40 hours, it is alternately sprayed 
with urine until saturated and allowed to dry 
without cleaning. Upon completion of the 
spray-dry cycling, the system is energized and 
functionally tested in a 100-percent oxygen 
atmosphere, ak 160’ F and 95-percent relative 
humidity. 
(11) Humidity. I n  a chamber held at  95- 
percent humidity, the system is operated at 
160’ F for 8 hours, then at 100’ F for 16 
more hours. This is repeated 10 times, giving 
240 hours of exposure. 
(12) Acaustic noise. The system is sub- 
jected for 30 minutes to an acoustic source pro- 
ducing an overall sound pressure level of 135 
db and a sound frequency distribution peak- 
ing between 300 and 600 Hz. 
(13) Acceleration. The system is subjected 
to simulated reentry accelerations applied 
separately along each major axis. The accel- 
erations yield 15.7-G resultants and last 30 
seconds. 
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(14) Vi6ration. The system is subjected to 
random vibration of 12.6-G RMS, having a 
power spectral density peaking between 200 
and 500 Hz. 
(15) Shock. The unenergized system is sub- 
jected to simulated landing shock (30 G for- 
ward and aft, 11 to 15 G lateral) and ultimate 
shock (40 G forward and aft, 15 to 20 G later- 
al) lasting about 11 milliseconds. Six impacts 
are applied, one for each direction along each 
principal axis. 
APPLICATION EVALUATION 
To date, no signal conditioner has failed in 
spacfiflight. The exacting manufacture, accept- 
ance, and qualification procedures, however, 
add to the equipment costs. 
TAB= 10-Production Operations for ApoZZo 
ECG Signa2 Conditioner 
Activity 
Parts (100% inspection) 
Secondary operations 
Assembly operations 
Welds 
Manufacturing inspections 
In-line functional tests 
In-line special tests 
Finishing operations 
Acceptance test operations 
Number 
121 
23 
31 
422 
33 
9 
7 
6 
87 
Total 739 
Table 10 summarizes the major operations 
required to produce an Apollo ECG signal 
conditioner (ref. 6). About 100 manhours are 
associated with the 739 activities. Of the 739 
activities, 57 percent are welding operations, 
and about 35 percent are inspection and test- 
ing. Inspection and testing are time consum- 
ing, so the 35 percent figure probably repre- 
sents a substantially greater portion of the 100 
manhours. 
NASA’s requirements for inspection testing 
and record keeping, particularly for com- 
ponent parts, are exceptional. Most likely they 
could be relaxed somewhat for nonaerospace 
applications at a considerable cost saving, 
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without significantly reducing unit reliabil- 
ity. Further savings would be provided by 
volume production, since much of NASA’s 
expense covers initial development efforts. But 
even if unit cost was lowered, bioinstnunenta- 
tion of comparable performance and rugged- 
ness would always remain relatively expensive. 
Are there nonaerospace applications for the 
type of instrumentation engendered by space- 
flight? It appears that there are. One applica- 
tion has developed in another realm of explor- 
ation-undersea habitation. Because nitrogen 
is narcotic at  great pressures, undersea facili- 
ties, such as the U. S. Navy’s Sealab I and 11, 
require a helium atmosphere. Helium is a light 
gas, easily permeating otherwise sealed elec- 
tronic units. At high pressures such an atmos- 
phere is destructive to much standard elec- 
tronic gear, making it difficult for scientific 
investigation, particularly physiological moni- 
toring, to be conducted underwater. Recently, 
a standard Gemini signal conditioner was 
tested in a simulated undersea environment to 
examine the general sturdiness of its design. 
Although originally designed to operate at  a 
near vacuum in 100-percent oxygen, the unit 
performed perfectly at 200 psig in 100-percent 
helium for several hours. A pressure of 200 
psig is equivalent to a depth of 430 feet, the 
planned level of the Sealab III habitation 
project. 
There are also other practical monitoring 
tasks for which the size, weight, power and 
reliability requirements placed on space equip- 
ment represent realistic system specifications. 
It has been proposed that helicopter rescue be 
initiated for the victims of highway accidents. 
Plans under consideration involve an instru- 
mented, telemetering “stretcher” (that would 
enable the central hospital emergency room to 
monitor a patient from the time he is con- 
tacted, while he is being transported, and dur- 
ing any necessary medical treatment. The 
elements of such a system are closely analo- 
gous to those of the space monitoring network; 
and the environmental contingencies of me- 
chanical shock, temperature extremes, and 
salt spray are also much the same. 
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Conclusions: 
CHAPTER 9 
Application of NASA Contributions 
I L  
The major aim of this survey has been to 
promote &he application of NASA bioin- 
strumentation contributions to nonaerospace 
medicine and industry. The preceding chap- 
ters have described a large number of con- 
tributions, selected from the many available, 
and have presented them in the framework 
of bioinstrumentakion system development. 
Additional citations and references have been 
supplied to lead the reader into the larger 
body of NASA’s work in the fie1d.l 
There appear to be three main avenues by 
which the objective of this report may be ful- 
filled; these are: 
(1) Primary transfer. 4 NASA technique 
or device is applied unchanged to a nonaero- 
space situation. 
(2) Secondartj trawfer. A NASA technique 
or device immediakely suggests a secondary 
development program, which leads to a tech- 
nological modification or extension for the 
nonaerospace situation. 
(3) Technical inficsion. Examination and 
discussion of NASA’s design approach and 
methodology promotes a heightened under- 
standing of biomedical engineering problems, 
facilitating- the subsequent manufacture and 
utilization of advanced bioinstrumentation in 
nonaerospace areas. 
Suggestions for primary and secondary 
transfer have been presented throughout the 
* A discussion of the medical market with reference 
to specific NASA innovations can be found in reference 
1. The general question of applying space technoIogy 
to medicine is treated by Hartwig (ref. 2) and Hart- 
wig and Bendersky (ref. 3 ) .  
survey, along with some examples of devices 
and techniques which have already made the 
transition. Every current bioinstrumentation 
trade magazine carries advertisements for nu- 
merous commercial variaDts of NASA-origi- 
nated and NASA-sponsored devices, The im- 
portance of .this type of transfer cannot be 
overemphasized, but to a large extent it de- 
pends upon the participation of specialists 
working within their areas of competence. 
Technical infusion, on the other hand, gener- 
ally depends on personnel crossing lines of 
specialization : the engineer considering the 
needs of medicine; the doctor applying tech- 
niques of engineering design and analysis, as 
well as employing engineering products. It is 
apparent today that a new cooperation is being 
established between the technological disci- 
plines and the field of medicine. Evidence of 
this is seen in the journals devoted to research 
and development in this field; for example: 
(1) The IEEE Transactions on Bio-Medical 
Engineering, (2) Medical &, Biological Engi- 
neering (formerly Medical Eleotronics and 
Biological Engineering ; the Journal of the 
International Federation for Medical and Bio- 
logical Engineering), and (3) Medical Re- 
search Engineering (formerly the American 
Journal of Medical Electronics), Further evi- 
dence is found in the proliferakion of trade 
magazines, symposia, and university curricula 
devoted .to the engineering-medical interaction. 
It is also apparent that while NASA cannot 
claim sole responsibility, it has provided much 
impetus for these promising interdisciplinary 
efforts. NASA has accomplished khis by using 
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medical personnel in the front line of complex 
technological planning and by closely involv- 
ing the aerospace industry in advanced bio- 
instrumentation programs. A climate of ap- 
pregiation has been established which yields 
a self-perpetuating “delayed fallout” of in- 
novation and improvement. 
For example, the senior author recently 
visited a major aerospace research and develop- 
ment firm. A design engineer there had de- 
veloped a compact and lightweight pneumatic 
pump for a specific space application. He had 
considered other potential uses of the device 
and had decided that it showed promise as an 
implgted heart-assist pump. Soon, a small re- 
search study was underway to test the feasibil- 
ity of this application. The firm had partici- 
pated previously in NASA-sponsored bioin- 
strumentation studies ; its engineers were used 
$0 thinking of medicine and engineering as 
interrelaked. Consequently, medical extension 
of an engineering solution was natural, where 
it might not have otherwise been. One can an- 
ticipate a great multiplication of such examples 
in .the future. 
The point here is that while several specific 
NASA contributions &o bioinstrumentation 
may reappear rapidly in no‘naerospace use, the 
most significant effects of the NASA develop- 
ment programs may be more diffuse. While the 
authors will be gratified if this survey aids 
designers or planners in the immediate trans- 
fer of aerospace technology, they will be 
equally pleased if it enhances $he climate of 
interdisciplinary cooperation and appreciation 
which in the future will make possible even 
greater advances. 
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Glossary 
acquisition, telemetry-interval of telemetry signal 
reception, e.g., from a spaceship. 
amplitude modulation (AM)--combining a signal with 
a carrier wave such that the carrier’s amplitude 
varies in accordance with the amplitude of the 
signal. 
analog-signals involving continuous variables. 
artifact-unwanted, spurious, stray, or random noise 
appearing in an electrical network. 
bandwidth-a continuous sequence of frequencies ; the 
extent of the sequence. 
bioelectric-electrical phenomena of, or associated 
with, living organisms. 
bioinstrumentation-devices associated with the meas- 
urement of physiological effects in living organisms. 
biotelemetry-pertaining to the transmission of physi- 
ological information over distance. 
cardiotachometer-device for calculation and record- 
ing of the heart rate. 
cardiovascular-pertaining to the heart, veins, arter- 
ies, capillaries, and the functions thereof. 
decibel (db)-a logarithmic unit for measuring any 
signal intensity; used as a measure of response in 
electrical communication circuits. 
demodulator-a device that extracts the original 
signal from the modulated carrier. 
differential amplifier-a device that amplifies the 
potential difference between two active inputs, refer- 
enced to a third. 
digital-signals, calculations, or displays involving 
discrete units. 
discriminator-the portion of an F M  circuit that 
changes frequency modulation to amplitude modula- 
tion. 
electroencephalogram (EEG)-a record of electrical 
brain waves made by an electroencephalograph. 
electroencephalograph-a device with leads to the 
scalp which records the electrical currents occurring 
in the cerebral cortex. 
electrocardiogram (ECG or EKG)-a tracing of the 
heart’s action currents ; used to determine abnor- 
malities in the heart. 
electrocardiograph-an instrument for recording 
changes in potential in the electrical currents which 
traverse the heart and initiate its contraction. 
ECG complex-referring to the periodic set of waves 
in the electrocardiogram ; the individual waves are 
identified as P, Q, R, B, and T. The QRB complex 
is often separately specified. 
electrolyte-a nonmetallic electric conductor in which 
current is carried by the movement of ions; a sub- 
stance that when dissolved in a suitable solvent, or 
when fused, becomes an ionic conductor. 
frequency-the number of times that a function re- 
peats during a unit time interval. 
frequency modulation (FM)-modulation of the fre- 
quency of a carrier wave in accordance with the 
amplitude of the input signal. 
frequency response-the band of frequencies a circuit 
will pass, or is sensitive to. 
gain-value representing the ratio of the increase in 
the output voltage of an amplifier to the change in 
input voltage. 
hard copy-printed information, in contrast to oscillo- 
scope presentation. 
Hertz (Hz)-unit designation for frequency. One 
Hertz is defined as one cycle per second. 
impedance-inherent resistance experienced by alter- 
nating current in an  electrical circuit. Mathemati- 
cally, it has a real and imaginary portion. 
integrated circuit-several electronic components in- 
tegrally part of the same substrate, generally quite 
small. 
multiplex-a technique by which several discrete elec- 
trical signals are transmitted on the same circuit. 
noise-any unwanted signal in an electronic circuit. 
on line-used during the actual operation, as on-line 
data processing. 
osciIlator-a circuit that  produces audio or radio 
signals at specific frequencies. 
phonocardiogram-a record of heart sounds made by 
means of a phonocardiograph. 
phonovibrocardiogram-a phonocardiogram extending 
into the very low (vibration) frequency regions. 
pneumotachometer-a device for recording the speed 
of air flow with respect to time; also, a device for 
recording breathing rate. 
qualification-demonstration of equipment ability to 
meet specified environmental stresses. 
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R-wave (also see ECG complex) -the first positive de- 
respiration tachometer (see pneumotachometer) 
root mean square (RMS)-a measure of average 
signal strength. 
signal-a detectable physical quantity or impulse by 
which information may be transmitted. 
signal-to-noise ratio-the ratio of desired to un- 
desired information. 
solid state-electronic circuitry contained on or within 
a semiconducting material such as silicon, gallium 
or germanium. A transistor is a solid-state element. 
specifications-technical parameters governing design, 
fabrication, or performance of equipment. 
flection of the QRS complex in the EGG. 
telemetry-process by which information is obtained 
and transmitted, usually by radio, to a distant re- 
ceiver. 
thermistor-a resistor made nf a material whose re- 
sistance varies in a known manner with tempera- 
ture. 
time line-a chart or diagram presenting a series of 
events in their progressive order. 
vectorcardiogram-a graphic representation of the 
magnitude and direction of the heart's action poten- 
tial ; three-dimensional EGG. 
weightlessness-zero gravity or freefall. 
ZPN,impedance pneumograph. 
Acceptance testing, of space bioinstrumentation, 80-81 
Advanced medical planning, 10-12 
Aeromedical console, Manned Spacecraft Center, 42-43 
Ames Research Center 
EEG sponge electrodes development, 21-22 
Implant telemetry development, 30-34 
Animal instrumentation, 30, 59, 63 
Apollo program 
Slight bioinstrumentation, 10, 17,26-29,69 
Flight data transmission, 37 
Medical monitoring, 41-43 
Planning, 10 
ApollO-X, 11 
Arterial blood pressure 
In medical monitoring, 74338-39 
Signal conditioner, 29-30 
In electrode systems, 15,16,19 
In  signal conditioning, 27 
Autocorrelation 
Definition, 54 
In  measurement of heart rate, 55 
Automated diagnosis, 45, 65 
Automatic waveform analysis, 51-53 
Autospectrogram 
Contour mapping in EEG waveform analysis, 58-59, 
Definition, 58 
Artifact (also see noise) 
Averaging, of biomedical signals, 51 
Aviation medicine, 7 
Bandwidth, in signal conditioning, 26 
Bioenvironmental information system 
Design evolution of,'43-45 
In  Gemini and Apollo medical monitoring, 37 
Development problems, 12 
Multiple function, 12 
Quality assurance, 80 
Specification and acquisition, 11-12 
Testing, 80-81 
Bioinstrumentation 
Biomedical preprocessor, 41 
Biotelemetry 
From space capsule, 37-38 
Implant, 30-34 
In medical monitoring, 7-8, 38-39 
Signal conditioner, 29-30 
Blood pressure, arterial 
Blood pressure, venous, 7 
Index 
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Body temperature 
In safety monitoring, 8, 9,38,39 
Sensors, 22-23 
Cardiotachometer 
In  medical monitoring, 38, 63 
Preprocessor for, 64 
Circulatory deconditioning, 9 
Coherence function 
Contours in EEG analysis, 60-61 
Definition, 60 
Common mode rejection, 27, 34, 35 
Computers 
In  biomedical data monitoring, 41-42, 44 
Data processing, 49-50, 65-66 
Small computers, 65-66 
Contourograph data display, 61-62 
Contour mapping 
EEG autospectrogram, 58-59 
EEG cdherence function, 60-61 
Cuff pressure, in blood pressure recording, 29,38 
Data processing 
Advanced NASA techniques, 45-46, 49 
Apollo, 41-42 
Gemini, 38, 40, 41 
Nonaerospace application, 45-46 
mination, 64 
Derivitives, in heart rate and respiratory rate deter- 
Digital data display, 41-42, 4 4  
Digital filter, 56-57 
Electrocardiogram (ECG) 
Contourograph display, 61 
Digital filtering, 56-57 
Electrodes, 15-19, 6%71 
In  medical monitoring, 7, 9, 10, 38, 39 
Power spectral density, 57-58 
Signal conditioner, 26-29, 34-35 
Electroencephalogram (EEG) 
Antospectrogram contour map, 58, 59 
Coherence contour map, 61 
Contourograph display, 63 
Electrodes, 19-22 
Electrodes 
ECC, 17-22 
Application, 17-18 
Design requirements, 15-16 
Placement, 18-19 
Spaceflight units, 16,17, 23 
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EEG, 19-22 
Long-term attachment, 17-18 
Paste, 17 
Spray-on, 69-71, 74 
Electrolyte (also electrode paste), 16, 19-21 
Electronic components 
Biotelemetry, 29, 31 
Helium effect on, 85 
Quality control in manufacture, 8145 
Encapsulation, in signal conditioner assembly, 80 
Extravehicular activity (EVA), 10 
Filter, digital, 56-57 
Flight Research Center 
Data processing activity, 51, 54, 56-57 
Mass spectrometer development, 71-73 
Spray-on electrode development, 68-71 
Frank lead network, 34 
Gas analysis, by mass spectrometer, 72 
Gas partial pressure, in respiratory analysis, 71-72 
Gemini program 
Experiments, 9-10 
Flight bioinstrumentation, 9, 16, 19, 21-22, 25-26, 
Flight data transmission, 3738 
Medical monitoring, 38-41 
Planning, 9-10 
29-30, 77-80, 85 
Handling, of space bioinstrumentation material, 80, 85 
Heart Rate 
Derivative, 64 
In  medical monitoring, 7, 54-55 
Illstrumentation, 38, 4142 
Presentation in monitoring, 38-43, 63-65 
Helicopter rescue, in highway accidents, 85 
High density packaging, 30-31, 77-78 
Human factors requirements, 10-11 
Impedance pneumograph 
Bioinstrumentation, 19-21, 34, 67-69 
Data presentation, 38-39 
In  medical monitoring, 7-8, 67 
Nonaerospace application, 74 
Information requirements, biomedical, 37 
Input impedance 
Bioinstrumentation amplifiers, 9, 27, 34-35, 71 
Definition, 27 
Inspection, space bioinstrumentation, 81-84 
Intensive care, 45-46 
Interdisciplinary efforts, and NASA bioinstrumenta- 
Korotkow sounds, 29-30, 38 
Lunar Excursion Module (LERI), 10 
Manned Spacecraft Center 
tion, 87-88 
Electrode development, 16 
Medical monitoring facilities, 38-43 
Spacecraft tracking network, 38 
FRC development, 71-73 
In  aerospace medical monitoring, 67, 71-72 
Nonaerospace application, 74 
Mass spectrometer 
Medical monitoring (see also safety monitoring) 
Apollo, 38-43 
Gemini, 34-41, 43-44 
Mercury, 43-44 
Planning, 5-6, 45 
Small computers, 65 
Mercury program 
Bioinstrumentation, 7-8, 16-18, 21 
Planning, 7-9 
Microminiaturization, 32-34 
Multiplex, 26 
Mylar templates, in signal conditioner assembly, 78 
NASA Headquarters, and bioinstrumentation 
NASA/AMES (see Ames Research Center) 
NASA/FRC (see Flight Research Center) 
NASA/MSC (see Manned Spacecraft Center) 
Noise 
Planning, 11-12 
Bioinstrumentation design, 25-26 
Data processing, 51-53, 55, 57-58 
EGG instrumentation, 25, 27, 3+35 
Electrode systems, 16-17 
Bioinstrumentation, 8, 22-23 
Data presentation, 3841 
Medical monitoring, 38-41 
Sensors, 22-23 
Oral temperature 
Orthostatic hypotension, 9 
Patient monitoring, 45 
Phonocardiogram, 4-10 
Phonovibrocardiogram, 34 
Power spectral density (also see autospectrogram) 
Definition, 57-58 
Of ECG signals, 57-58 
In  EEG analysis, 58-59 
Power supply, for implant biotelemetry, 33-34 
Pressure transducer, 30 
Pressure transducer, for blood pressure measurement, 
Probe, rectal temperature, 22 
Procurement, of space bioinstrumentation components 
Quality assurance, for space bioinstrumentation, 80 
Quality control, in space bioinstrumentation 
R Wave, 53,55,57,62 
Resistance, skin-to-electrode, 16-17 
Respiration rate 
30 
80 
Fabrication, 80 
Bioinstrumentation, 8, 38, 41, 64-65 
Data presentation, 38-42 
In  medical monitoring, 8 I 
Impedance pneumography measurement, 8, 34, 67- 
Respiration waveform (respiration volume) 
69 
Safety monitoring, 7-10 
Sampling rate, and biomedical data 
processing, 49 
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Scalp electrodes, 19-21 
Sensor 
Body temperature, 8, 22-23 
EEG, 19-22 
Oral temperature, 8,22 
Pressure, 29-30 
53 
Apollo EGG, 26-29 
Design considerations, 25-26 
Fabrication and qualification, 77-85 
Gemini blood pressure, 29-30 
Impedance pneumograph, 34, 67-69 
Implant telemetry, 30-34 
Location, 26 
Nonaerospace application, 3435, 85 
Phonovibrocardiogram, 34 
Vectorcardiograph, 34 
Signal filtering, 26, 30, 49, 56 
Signal-to-noise ratio, 50, 55-56 
Silver chloride and wet electrodes, 16, 19-22 
Skin 
EGG, 15-19, 
Signal averaging (see also waveform averaging), 49, 
Signal conditioner, 
Electrode interface, 15-16 
Preparation for electrodes, 17-19, 69-71 
Temperature, 23 
Small computers, in medical monitoring, 65-66 
Source impedance, 27-29 
Space Task Group, and Mercury planning, 7 
Sphygmomanometer, 7-8 
Sphygmomanometry, indirect, 29-30 
Stannous chloride, as electrode 
Strip chart recorder, in biomedical data 
Systolic pressure, 30 
Tape recording 
Electrolyte, 21 
Presentation, 38-39, 4 1 4 3  
In flight, 8-10 
In data analysis, 42-44 
Technology transfer, 87 
Temperature, Gemini physiological, 40-41 
Temperature sensor, 
Body, 22-23 
Oral, 22-23 
Skin, 23 
Acceptance, 80-81, 84 
Qualification, 81-85 
Testing of space bioinstrumentation 
Timeline data analysis, 49-50 
Tracking stations, in Gemini/Apollo 
Data transmission, 37-38 
Vectorcardiograph, 34 
Waveform averaging, 61-63 
Weightlessness, and medical planning, 7-8 
Welding, in signal conditioner assembly, 78-79 
White noise, 57 
X-15 aircraft, 56 
“Yes/No” data reduction, 49, 51-53 
Zephyran chloride, in electrode application, 18 
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